Gene	Gene synonym	Ensembl	Gene description	Chromosome	Position	Protein class	Evidence	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Prognostic p-value	RNA cancer category	RNA tissue category	RNA TS	RNA TS TPM	TPM max in non-specific	RNA cell line category	RNA CS	RNA CS TPM
LRCH4	LRN, LRRN1	ENSG00000077454	Leucine rich repeats and calponin homology domain containing 4	7	100574011-100586153	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA037667, HPA037668	Enhanced		Approved	Nucleoplasm<br>Focal adhesion sites<br>Cytosol	Colorectal cancer:1.61e-7 (unfavourable)	Expressed in all	Expressed in all			spleen: 105.8	Expressed in all		
POFUT2	C21orf80, FUT13, KIAA0958	ENSG00000186866	Protein O-fucosyltransferase 2	21	45263928-45287898	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA044297	Uncertain				Renal cancer:8.66e-12 (unfavourable), Colorectal cancer:4.55e-7 (unfavourable), Liver cancer:2.78e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 24.3	Expressed in all		
CLK3	clk3	ENSG00000179335	CDC like kinase 3	15	74598500-74645414	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA046817	Approved		Supported	Nucleoplasm<br>Intermediate filaments	Colorectal cancer:2.05e-6 (unfavourable), Prostate cancer:5.92e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 71.7	Expressed in all		
EGFL7	ZNEU1	ENSG00000172889	EGF like domain multiple 7	9	136658856-136672678	Predicted secreted proteins	Evidence at protein level	HPA050716	Approved				Colorectal cancer:4.22e-6 (unfavourable), Renal cancer:5.28e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 263.7	Cell line enhanced		EFO-21: 172.9;HUVEC TERT2: 276.0;TIME: 254.4
DPP7	DPP2, DPPII	ENSG00000176978	Dipeptidyl peptidase 7	9	137110542-137115177	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA021282, CAB025541, HPA059381	Supported		Enhanced	Golgi apparatus<br>Vesicles	Colorectal cancer:6.07e-6 (unfavourable), Pancreatic cancer:8.31e-5 (favourable)	Expressed in all	Expressed in all			adrenal gland: 70.7	Mixed		
HSH2D	ALX, FLJ14886, HSH2	ENSG00000196684	Hematopoietic SH2 domain containing	19	16134028-16158575	Predicted intracellular proteins	Evidence at protein level	HPA036616			Approved	Plasma membrane<br>Focal adhesion sites<br>Cytosol	Renal cancer:6.49e-6 (unfavourable), Colorectal cancer:9.46e-6 (unfavourable), Urothelial cancer:3.47e-5 (favourable)	Mixed	Mixed			tonsil: 32.7	Cell line enhanced		HMC-1: 49.9;NB-4: 88.6;RPMI-8226: 43.5;U-937: 106.3
ASB6		ENSG00000148331	Ankyrin repeat and SOCS box containing 6	9	129634604-129642169	Predicted intracellular proteins	Evidence at protein level	HPA004341	Approved				Colorectal cancer:1.06e-5 (unfavourable), Liver cancer:2.40e-5 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 22.7	Expressed in all		
SPAG4	CT127, SUN4	ENSG00000061656	Sperm associated antigen 4	20	35615892-35621049	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA048393, HPA061789	Approved				Endometrial cancer:9.52e-8 (favourable), Colorectal cancer:1.09e-5 (unfavourable), Glioma:8.89e-5 (unfavourable), Renal cancer:1.28e-4 (unfavourable), Urothelial cancer:6.66e-4 (favourable)	Expressed in all	Mixed			testis: 22.5	Cell line enhanced		EFO-21: 25.0;U-87 MG: 46.8
EXOC3L4	C14orf73	ENSG00000205436	Exocyst complex component 3 like 4	14	103100144-103110559	Predicted intracellular proteins	Evidence at protein level	HPA043661	Approved				Colorectal cancer:1.43e-5 (unfavourable)	Tissue enhanced	Tissue enhanced		duodenum: 19.2	small intestine: 10.7	Cell line enhanced		HDLM-2: 3.5;HEL: 3.4;Hep G2: 1.8;RPMI-8226: 1.8
HSPA1A	HSP70-1, HSPA1	ENSG00000204389	Heat shock protein family A (Hsp70) member 1A	6	31815464-31817946	Predicted intracellular proteins	Evidence at protein level	CAB017451, CAB032815, HPA052504	Supported		Approved	Nucleoplasm<br>Vesicles	Colorectal cancer:1.54e-5 (unfavourable)	Expressed in all	Mixed			adrenal gland: 49.9	Cell line enriched	10	HEK 293: 3834.6
PAQR6	FLJ22672, PRdelta	ENSG00000160781	Progestin and adipoQ receptor family member 6	1	156243321-156248117	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA073505			Approved	Nucleus<br>Nucleoli	Renal cancer:1.58e-8 (unfavourable), Colorectal cancer:1.60e-5 (unfavourable), Urothelial cancer:1.86e-4 (favourable), Prostate cancer:1.99e-4 (unfavourable)	Tissue enriched	Tissue enriched	9	cerebral cortex: 97.5	skin: 10.7	Cell line enhanced		U-266/70: 19.6
FAM69B	C9orf136, MGC20262	ENSG00000165716	Family with sequence similarity 69 member B	9	136712570-136724050	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA046812, HPA054443	Uncertain		Approved	Nucleus<br>Nuclear bodies<br>Vesicles	Colorectal cancer:1.77e-5 (unfavourable), Pancreatic cancer:9.48e-5 (favourable)	Expressed in all	Mixed			placenta: 29.6	Cell line enhanced		EFO-21: 67.2;HEK 293: 59.7;HUVEC TERT2: 67.6
CRACR2B	EFCAB4A, MGC45840	ENSG00000177685	Calcium release activated channel regulator 2B	11	826144-831991	Predicted intracellular proteins	Evidence at protein level	HPA046217	Approved				Colorectal cancer:1.81e-5 (unfavourable)	Expressed in all	Tissue enhanced		salivary gland: 120.0	stomach: 56.6	Cell line enhanced		HDLM-2: 30.7;SK-BR-3: 92.6
ARHGAP4	C1, KIAA0131, p115, RhoGAP4, SrGAP4	ENSG00000089820	Rho GTPase activating protein 4	X	153907367-153934999	Predicted intracellular proteins	Evidence at protein level	HPA001012, HPA001083	Enhanced		Approved	Nucleoplasm<br>Focal adhesion sites	Colorectal cancer:1.97e-5 (unfavourable), Cervical cancer:3.94e-5 (favourable), Renal cancer:2.49e-4 (unfavourable), Head and neck cancer:3.31e-4 (favourable)	Expressed in all	Tissue enhanced		spleen: 95.1	lymph node: 87.2	Cell line enhanced		MOLT-4: 72.4;RPMI-8226: 121.4
NPDC1	CAB-, CAB1, DKFZp586J0523	ENSG00000107281	Neural proliferation, differentiation and control 1	9	137039470-137046203	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA008189	Approved		Approved	Nucleus<br>Cytosol	Colorectal cancer:2.01e-5 (unfavourable), Endometrial cancer:6.19e-5 (favourable), Pancreatic cancer:3.18e-4 (favourable)	Expressed in all	Expressed in all			prostate: 124.2	Mixed		
DAPK1	DAPK	ENSG00000196730	Death associated protein kinase 1	9	87497228-87708633	Cancer-related genes, Enzymes, Predicted membrane proteins	Evidence at protein level	CAB037302, HPA040472, HPA048436	Approved		Approved	Centrosome	Colorectal cancer:2.48e-5 (unfavourable)	Expressed in all	Mixed			lung: 56.3	Cell line enhanced		HMC-1: 85.8
CNPY3	CAG4A, TNRC5	ENSG00000137161	Canopy FGF signaling regulator 3	6	42929192-42939287	Predicted secreted proteins	Evidence at protein level	HPA016560	Uncertain				Renal cancer:9.85e-6 (unfavourable), Colorectal cancer:3.03e-5 (unfavourable)	Expressed in all	Expressed in all			spleen: 103.1	Expressed in all		
ARL8A	ARL10B, FLJ45195, Gie2	ENSG00000143862	ADP ribosylation factor like GTPase 8A	1	202133404-202144743	Predicted intracellular proteins	Evidence at protein level	HPA038759, HPA040515, HPA045924	Approved				Colorectal cancer:3.08e-5 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 113.6	Expressed in all		
INAFM1	PRR24	ENSG00000257704	InaF motif containing 1	19	47274453-47275707	Predicted intracellular proteins	Evidence at transcript level	HPA064015	Uncertain				Colorectal cancer:3.20e-5 (unfavourable), Renal cancer:3.04e-4 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 23.3	Expressed in all		
RHBDD2	NPD007, RHBDL7	ENSG00000005486	Rhomboid domain containing 2	7	75842602-75888926	Enzymes, Predicted membrane proteins	Evidence at protein level	HPA045074, HPA051960	Uncertain		Enhanced	Golgi apparatus	Renal cancer:8.68e-6 (favourable), Colorectal cancer:3.31e-5 (unfavourable), Glioma:1.25e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 258.6	Expressed in all		
SEMA4C	Semacl1, Semaf, SEMAI	ENSG00000168758	Semaphorin 4C	2	96859716-96870757	Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	HPA011090	Approved				Renal cancer:9.50e-7 (unfavourable), Colorectal cancer:3.53e-5 (unfavourable)	Expressed in all	Expressed in all			placenta: 62.9	Cell line enriched	6	BEWO: 298.1
GDI1	FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4	ENSG00000203879	GDP dissociation inhibitor 1	X	154436913-154443467	Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB012979, HPA049290, HPA057668	Enhanced		Approved	Vesicles	Colorectal cancer:3.83e-5 (unfavourable), Breast cancer:6.84e-4 (unfavourable)	Expressed in all	Tissue enriched	5	cerebral cortex: 532.0	smooth muscle: 101.3	Expressed in all		
SLC10A3	DXS253E, P3	ENSG00000126903	Solute carrier family 10 member 3	X	154487306-154490690	Predicted membrane proteins, Predicted secreted proteins, Transporters	Evidence at protein level	HPA021656	Approved		Approved	Intermediate filaments	Colorectal cancer:4.15e-5 (unfavourable), Cervical cancer:4.53e-4 (favourable), Pancreatic cancer:7.22e-4 (unfavourable)	Expressed in all	Expressed in all			gallbladder: 33.0	Expressed in all		
PI4K2A	DKFZP761G1923, PI4KII, PIK42A	ENSG00000155252	Phosphatidylinositol 4-kinase type 2 alpha	10	97640686-97676434	Enzymes, Predicted intracellular proteins	Evidence at protein level	CAB030649	Approved				Colorectal cancer:4.21e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 31.3	Expressed in all		
HOMER3	HOMER-3	ENSG00000051128	Homer scaffolding protein 3	19	18929201-18941261	Predicted intracellular proteins	Evidence at protein level	CAB032656, HPA040999, CAB079015	Enhanced	Supported	Supported	Plasma membrane<br>Cytosol<br>Cytoplasmic bodies	Colorectal cancer:4.24e-5 (unfavourable), Liver cancer:4.93e-5 (unfavourable)	Expressed in all	Expressed in all			spleen: 150.5	Mixed		
HSD17B14	DHRS10, retSDR3, SDR47C1	ENSG00000087076	Hydroxysteroid 17-beta dehydrogenase 14	19	48813017-48836678	Predicted intracellular proteins	Evidence at protein level	HPA021467	Approved				Pancreatic cancer:2.87e-5 (favourable), Colorectal cancer:4.39e-5 (unfavourable)	Expressed in all	Mixed			kidney: 53.3	Cell line enhanced		HHSteC: 35.4;Karpas-707: 35.4;RT4: 28.6
NPC2	EDDM1, HE1, NP-C2	ENSG00000119655	NPC intracellular cholesterol transporter 2	14	74476192-74494177	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters	Evidence at protein level	HPA000835	Enhanced				Colorectal cancer:4.83e-5 (unfavourable), Stomach cancer:2.66e-4 (unfavourable), Liver cancer:3.13e-4 (unfavourable), Thyroid cancer:6.55e-4 (favourable)	Expressed in all	Tissue enriched	19	epididymis: 16336.0	lung: 849.0	Expressed in all		
CRYAB	CRYA2, HSPB5	ENSG00000109846	Crystallin alpha B	11	111908565-111923722	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	CAB002053, CAB040560, HPA057100	Enhanced		Enhanced	Plasma membrane<br>Cytosol	Urothelial cancer:1.70e-5 (unfavourable), Colorectal cancer:4.90e-5 (unfavourable)	Group enriched	Tissue enhanced		heart muscle: 3968.4	cerebral cortex: 1888.7	Cell line enhanced		ASC diff: 1679.2;fHDF/TERT166: 650.9;U-138 MG: 315.9
LIMK1	LIMK	ENSG00000106683	LIM domain kinase 1	7	74082933-74122525	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Evidence at protein level	HPA028064, HPA028516	Approved		Supported	Nuclear speckles<br>Cytosol	Renal cancer:6.63e-8 (unfavourable), Liver cancer:7.79e-6 (unfavourable), Colorectal cancer:4.95e-5 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 39.5	Expressed in all		
PYCR2	P5CR2	ENSG00000143811	Pyrroline-5-carboxylate reductase family member 2	1	225919877-225924340	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Evidence at protein level	HPA056873	Approved		Approved	Mitochondria	Renal cancer:1.42e-6 (unfavourable), Colorectal cancer:5.02e-5 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 71.9	Expressed in all		
RRNAD1	C1orf66, CGI-41, METTL25B	ENSG00000143303	Ribosomal RNA adenine dimethylase domain containing 1	1	156728442-156736960	Predicted intracellular proteins, Predicted membrane proteins	Evidence at transcript level	HPA047426	Approved		Approved	Nucleoli<br>Cytosol	Colorectal cancer:5.60e-5 (unfavourable)	Expressed in all	Expressed in all			thyroid gland: 49.2	Expressed in all		
CALB2	CAL2	ENSG00000172137	Calbindin 2	16	71358713-71390438	Plasma proteins, Predicted intracellular proteins, Transporters	Evidence at protein level	CAB000106, HPA007305, HPA007306	Enhanced	Supported	Enhanced	Cytosol	Colorectal cancer:5.78e-5 (unfavourable)	Mixed	Tissue enhanced		adipose tissue: 54.6;testis: 24.9	adrenal gland: 12.7	Cell line enhanced		HEL: 57.0;HMC-1: 116.3;U-2 OS: 39.2
GPC1	glypican	ENSG00000063660	Glypican 1	2	240435671-240468078	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA030571	Approved		Supported	Plasma membrane<br>Cytosol	Liver cancer:2.44e-6 (unfavourable), Colorectal cancer:5.78e-5 (unfavourable), Endometrial cancer:1.55e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 265.8	prostate: 67.5	Mixed		
VAMP1	SYB1, VAMP-1	ENSG00000139190	Vesicle associated membrane protein 1	12	6462237-6470987	FDA approved drug targets, Predicted membrane proteins, Transporters	Evidence at protein level	CAB002779, CAB016119, CAB079000	Approved	Approved			Renal cancer:1.04e-11 (unfavourable), Colorectal cancer:6.37e-5 (unfavourable), Liver cancer:6.97e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 43.5	Cell line enriched	5	U-698: 140.4
PPP1R3E	FLJ00089	ENSG00000235194	Protein phosphatase 1 regulatory subunit 3E	14	23295643-23302848	Predicted intracellular proteins	Evidence at protein level	HPA061600	Approved		Approved	Microtubules<br>Mitotic spindle<br>Mitochondria	Colorectal cancer:6.89e-5 (unfavourable), Lung cancer:3.10e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 14.5	Cell line enhanced		U-266/70: 31.3
HOXD13	HOX4I, SPD	ENSG00000128714	Homeobox D13	2	176092891-176095938	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA064064			Supported	Nucleus	Colorectal cancer:6.95e-5 (unfavourable)	Mixed	Group enriched	8	cervix, uterine: 7.9;colon: 4.9;prostate: 16.9;rectum: 9.5;seminal vesicle: 24.5	urinary bladder: 1.5	Cell line enhanced		HAP1: 20.6;HEK 293: 52.3;HL-60: 52.4;NB-4: 24.7;SCLC-21H: 19.3
ALAD	ALADH, PBGS	ENSG00000148218	Aminolevulinate dehydratase	9	113386317-113401333	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA021023, HPA022124	Enhanced				Colorectal cancer:7.33e-5 (unfavourable), Liver cancer:8.80e-5 (favourable), Renal cancer:1.65e-4 (favourable), Endometrial cancer:5.64e-4 (favourable)	Expressed in all	Expressed in all			adrenal gland: 147.1	Expressed in all		
ADARB1	ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1	ENSG00000197381	Adenosine deaminase, RNA specific B1	21	45073853-45226560	Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA029645			Supported	Nucleoplasm<br>Cytosol	Colorectal cancer:8.16e-5 (unfavourable), Renal cancer:3.56e-4 (unfavourable)	Expressed in all	Expressed in all			lung: 30.2	Cell line enhanced		HHSteC: 55.4
HSF4	CTM	ENSG00000102878	Heat shock transcription factor 4	16	67164681-67169945	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA048584			Supported	Nuclear speckles	Renal cancer:2.19e-6 (unfavourable), Colorectal cancer:8.24e-5 (unfavourable)	Expressed in all	Mixed			adrenal gland: 14.8	Cell line enhanced		T-47d: 12.3;U-266/70: 18.1
ARHGEF17	KIAA0337, p164-RhoGEF, TEM4	ENSG00000110237	Rho guanine nucleotide exchange factor 17	11	73308289-73369091	Predicted intracellular proteins	Evidence at protein level	HPA007991	Uncertain		Approved	Cytosol	Colorectal cancer:8.27e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 37.6	Mixed		
JDP2	JUNDM2	ENSG00000140044	Jun dimerization protein 2	14	75427716-75474111	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059511	Supported		Approved	Nucleoplasm<br>Nuclear speckles	Colorectal cancer:8.58e-5 (unfavourable)	Expressed in all	Expressed in all			spleen: 85.7	Cell line enhanced		HHSteC: 140.4
MGEA5	MEA5, NCOAT, OGA	ENSG00000198408	Meningioma expressed antigen 5 (hyaluronidase)	10	101784443-101818465	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA036141, HPA076501	Approved		Supported	Cytosol	Colorectal cancer:8.69e-5 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 129.4	Expressed in all		
COMP	EDM1, EPD1, MED, PSACH, THBS5	ENSG00000105664	Cartilage oligomeric matrix protein	19	18782773-18791314	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA077555			Approved	Golgi apparatus	Renal cancer:1.52e-6 (unfavourable), Colorectal cancer:9.08e-5 (unfavourable), Endometrial cancer:2.04e-4 (unfavourable), Urothelial cancer:6.95e-4 (unfavourable)	Mixed	Tissue enhanced		gallbladder: 24.5	smooth muscle: 18.2	Cell line enriched	5	fHDF/TERT166: 666.2
AMH	MIS	ENSG00000104899	Anti-Mullerian hormone	19	2249309-2252073	Disease related genes, Predicted secreted proteins	Evidence at protein level	HPA066973			Approved	Vesicles<br>Aggresome	Colorectal cancer:9.21e-5 (unfavourable)	Mixed	Tissue enriched	6	testis: 1.6	cerebral cortex: 0.2	Cell line enhanced		HEK 293: 15.7;NTERA-2: 6.5;REH: 6.4;SH-SY5Y: 8.2
GPRC5B	RAIG-2	ENSG00000167191	G protein-coupled receptor class C group 5 member B	16	19856691-19886167	G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA015247	Enhanced		Supported	Nucleus<br>Nucleoli<br>Vesicles	Colorectal cancer:9.27e-5 (unfavourable), Renal cancer:6.30e-4 (favourable)	Expressed in all	Tissue enhanced		cerebral cortex: 308.3	testis: 66.2	Cell line enhanced		EFO-21: 84.6;HHSteC: 50.7
KCNE4	MiRP3	ENSG00000152049	Potassium voltage-gated channel subfamily E regulatory subunit 4	2	223051814-223198399	Predicted membrane proteins	Evidence at protein level	HPA011420	Approved		Approved	Nuclear bodies<br>Microtubules	Renal cancer:2.02e-7 (unfavourable), Colorectal cancer:9.42e-5 (unfavourable)	Expressed in all	Tissue enhanced		smooth muscle: 54.0	endometrium: 33.5	Cell line enriched	6	AN3-CA: 152.4
FAM50A	9F, DXS9928E, HXC-26, XAP5	ENSG00000071859	Family with sequence similarity 50 member A	X	154444126-154450654	Predicted intracellular proteins	Evidence at protein level	HPA003585	Supported		Enhanced	Nucleoplasm	Liver cancer:3.15e-5 (unfavourable), Colorectal cancer:9.52e-5 (unfavourable), Cervical cancer:2.05e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 67.0	Expressed in all		
TMEM106A	MGC20235	ENSG00000184988	Transmembrane protein 106A	17	43211835-43220041	Predicted membrane proteins	Evidence at transcript level						Colorectal cancer:9.61e-5 (unfavourable)	Expressed in all	Mixed			kidney: 23.2	Mixed		
PHF1	MTF2L2, PCL1, TDRD19C	ENSG00000112511	PHD finger protein 1	6	33410399-33416453	Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA031038	Approved		Approved	Nucleoplasm	Colorectal cancer:9.64e-5 (unfavourable), Urothelial cancer:1.72e-4 (favourable)	Expressed in all	Mixed			testis: 16.0	Mixed		
PRELP	prolargin, SLRR2A	ENSG00000188783	Proline and arginine rich end leucine rich repeat protein	1	203475828-203491352	Plasma proteins, Predicted secreted proteins	Evidence at protein level						Renal cancer:5.62e-6 (unfavourable), Colorectal cancer:9.70e-5 (unfavourable), Urothelial cancer:1.02e-4 (unfavourable)	Expressed in all	Mixed			seminal vesicle: 108.0	Group enriched	7	ASC diff: 12.4;BJ: 6.5;fHDF/TERT166: 9.1
MTHFSD	FLJ12998	ENSG00000103248	Methenyltetrahydrofolate synthetase domain containing	16	86530176-86555235	Predicted intracellular proteins	Evidence at protein level	HPA041333	Uncertain		Approved	Nucleus<br>Vesicles	Colorectal cancer:9.88e-5 (unfavourable)	Expressed in all	Expressed in all			testis: 33.0	Mixed		
HSPB1	CMT2F, Hs.76067, Hsp25, HSP27, HSP28	ENSG00000106211	Heat shock protein family B (small) member 1	7	76302544-76304295	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA000497, CAB004439, CAB047330, CAB047331, CAB047332	Enhanced		Enhanced	Plasma membrane<br>Cytosol	Colorectal cancer:9.94e-5 (unfavourable)	Expressed in all	Expressed in all			esophagus: 1615.3	Expressed in all		
AGAP9	bA301J7.2, CTGLF6, FLJ00312	ENSG00000204172	ArfGAP with GTPase domain, ankyrin repeat and PH domain 9	10	47501854-47523638	Predicted intracellular proteins	Evidence at transcript level	HPA042490	Uncertain				Renal cancer:3.02e-5 (unfavourable), Colorectal cancer:9.98e-5 (unfavourable), Urothelial cancer:7.04e-4 (favourable)	Expressed in all	Expressed in all			skin: 26.3	Mixed		
DNAJB2	CMT2T, HSJ1, HSPF3	ENSG00000135924	DnaJ heat shock protein family (Hsp40) member B2	2	219279267-219286900	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA036268	Approved		Enhanced	Nuclear membrane	Colorectal cancer:1.01e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 161.8	Expressed in all		
LMBR1L	FLJ10494, KIAA1174	ENSG00000139636	Limb development membrane protein 1 like	12	49096551-49110900	Predicted membrane proteins	Evidence at protein level						Renal cancer:4.45e-7 (unfavourable), Colorectal cancer:1.04e-4 (unfavourable), Pancreatic cancer:3.50e-4 (favourable)	Expressed in all	Tissue enhanced		testis: 27.9	endometrium: 9.1	Expressed in all		
WBP1	WBP-1	ENSG00000239779	WW domain binding protein 1	2	74458329-74460891	Predicted membrane proteins	Evidence at protein level	HPA057067	Approved		Approved	Cytosol	Colorectal cancer:1.04e-4 (unfavourable), Urothelial cancer:6.36e-4 (favourable), Pancreatic cancer:6.83e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 91.5	Expressed in all		
CYHR1	CHRP, KIAA0496, MGC13010	ENSG00000187954	Cysteine and histidine rich 1	8	144449582-144465677	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	HPA053653, HPA059543	Approved		Enhanced	Nucleoplasm	Colorectal cancer:1.05e-4 (unfavourable), Liver cancer:3.90e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 51.4	Expressed in all		
IGFBP3	BP-53, IBP3	ENSG00000146674	Insulin like growth factor binding protein 3	7	45912245-45921874	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB010360			Approved	Nucleoplasm<br>Vesicles<br>Cytosol	Renal cancer:5.07e-7 (unfavourable), Colorectal cancer:1.08e-4 (unfavourable), Liver cancer:1.64e-4 (unfavourable)	Expressed in all	Tissue enhanced		placenta: 2671.0	endometrium: 886.0	Cell line enhanced		fHDF/TERT166: 6647.1;U-2197: 3223.6;U-87 MG: 1735.3
FAM167B	C1orf90, MGC10820	ENSG00000183615	Family with sequence similarity 167 member B	1	32247233-32248856	Predicted intracellular proteins	Evidence at protein level	HPA029398, HPA062074	Approved		Approved	Actin filaments	Colorectal cancer:1.11e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 9.4	Cell line enhanced		EFO-21: 11.4;SK-MEL-30: 23.7;U-2197: 28.2
TMEM184A	MGC9712, SDMG1	ENSG00000164855	Transmembrane protein 184A	7	1542235-1560821	Predicted membrane proteins	Evidence at protein level	HPA053790, HPA071312	Uncertain		Approved	Nucleoplasm	Colorectal cancer:1.12e-4 (unfavourable), Thyroid cancer:9.94e-4 (unfavourable)	Mixed	Tissue enhanced		skin: 33.5	esophagus: 26.5	Cell line enhanced		SCLC-21H: 43.0;SK-BR-3: 42.7;T-47d: 47.5
TMEM88	FLJ20025, MGC71744	ENSG00000167874	Transmembrane protein 88	17	7855065-7856099	Predicted membrane proteins	Evidence at protein level	HPA052991	Approved				Liver cancer:4.43e-6 (favourable), Colorectal cancer:1.16e-4 (unfavourable)	Expressed in all	Mixed			placenta: 34.2	Group enriched	5	AN3-CA: 60.4;HHSteC: 35.4;HUVEC TERT2: 42.7;NTERA-2: 26.4
ALDH3B1	ALDH7	ENSG00000006534	Aldehyde dehydrogenase 3 family member B1	11	68008578-68029282	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA038525	Uncertain				Colorectal cancer:1.18e-4 (unfavourable), Pancreatic cancer:6.07e-4 (unfavourable)	Expressed in all	Tissue enhanced		fallopian tube: 64.4;lung: 67.7	bone marrow: 30.7	Cell line enhanced		A549: 137.9;CAPAN-2: 136.9
FKBP8	FKBP38, FKBPr38	ENSG00000105701	FK506 binding protein 8	19	18531751-18544077	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	CAB025346, HPA045177	Supported		Supported	Endoplasmic reticulum<br>Mitochondria<br>Cytosol	Colorectal cancer:1.24e-4 (unfavourable), Pancreatic cancer:7.76e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 354.7	Expressed in all		
S1PR3	EDG-3, EDG3	ENSG00000213694	Sphingosine-1-phosphate receptor 3	9	88991447-89005010	G-protein coupled receptors, Predicted membrane proteins	Evidence at protein level						Renal cancer:7.91e-6 (unfavourable), Colorectal cancer:1.30e-4 (unfavourable), Breast cancer:5.91e-4 (favourable)	Expressed in all	Mixed			smooth muscle: 52.4	Cell line enhanced		AF22: 117.8;ASC diff: 111.7;ASC TERT1: 114.8
GATAD2B	P66beta	ENSG00000143614	GATA zinc finger domain containing 2B	1	153789030-153923360	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA017015	Approved		Enhanced	Nucleoplasm	Colorectal cancer:1.30e-4 (unfavourable), Renal cancer:3.08e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 19.7	Expressed in all		
SEZ6L2	FLJ90517, PSK-1	ENSG00000174938	Seizure related 6 homolog like 2	16	29871159-29899547	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	HPA064471	Enhanced				Colorectal cancer:1.31e-4 (unfavourable), Glioma:7.27e-4 (unfavourable), Cervical cancer:7.46e-4 (unfavourable)	Expressed in all	Tissue enhanced		cerebral cortex: 82.4;parathyroid gland: 58.4	adrenal gland: 30.6	Cell line enhanced		EFO-21: 72.2
WWC3	BM042, KIAA1280	ENSG00000047644	WWC family member 3	X	10015562-10144478	Predicted intracellular proteins	Evidence at protein level	HPA039814	Uncertain		Approved	Actin filaments<br>Cytosol	Renal cancer:1.06e-5 (unfavourable), Colorectal cancer:1.31e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 39.8	Cell line enhanced		T-47d: 129.2
THAP3		ENSG00000041988	THAP domain containing 3	1	6624866-6635586	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA067114	Approved		Approved	Nucleus	Colorectal cancer:1.33e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 18.0	Expressed in all		
VSIG4	Z39IG	ENSG00000155659	V-set and immunoglobulin domain containing 4	X	66021738-66040125	Plasma proteins, Predicted membrane proteins	Evidence at protein level	HPA003903, CAB026000	Approved		Uncertain	Nucleoli<br>Plasma membrane<br>Cytosol	Renal cancer:1.95e-6 (unfavourable), Colorectal cancer:1.34e-4 (unfavourable)	Expressed in all	Expressed in all			lung: 243.4	Not detected		
TBC1D10B	DKFZP434P1750, EPI64B, FLJ13130, Rab27A-GAPbeta	ENSG00000169221	TBC1 domain family member 10B	16	30357102-30370264	Predicted intracellular proteins	Evidence at protein level	HPA048894	Uncertain				Liver cancer:8.94e-5 (unfavourable), Colorectal cancer:1.35e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 36.1	Expressed in all		
DENND6B	AFI1B, FAM116B, MGC33692	ENSG00000205593	DENN domain containing 6B	22	50309030-50327060	Predicted intracellular proteins	Evidence at protein level	HPA018934, HPA021653, HPA029570	Uncertain		Uncertain	Plasma membrane	Endometrial cancer:5.93e-5 (favourable), Colorectal cancer:1.41e-4 (unfavourable)	Expressed in all	Tissue enhanced		fallopian tube: 21.5	cerebral cortex: 12.0	Mixed		
INHBB		ENSG00000163083	Inhibin beta B subunit	2	120346143-120351808	Cancer-related genes, Predicted secreted proteins	Evidence at protein level						Thyroid cancer:1.02e-4 (favourable), Colorectal cancer:1.44e-4 (unfavourable), Renal cancer:3.02e-4 (unfavourable)	Expressed in all	Tissue enhanced		testis: 27.1	adipose tissue: 24.9	Cell line enhanced		A549: 42.9;ASC diff: 43.3;MCF7: 44.4;PC-3: 85.1;SK-BR-3: 122.2
GAS1		ENSG00000180447	Growth arrest specific 1	9	86944363-86947189	Cancer-related genes, Predicted secreted proteins	Evidence at protein level	CAB024164, HPA036085, HPA066902	Approved		Approved	Nuclear speckles	Thyroid cancer:1.13e-5 (unfavourable), Renal cancer:1.96e-5 (unfavourable), Colorectal cancer:1.55e-4 (unfavourable), Stomach cancer:8.26e-4 (unfavourable)	Expressed in all	Tissue enhanced		endometrium: 110.8	smooth muscle: 74.4	Cell line enhanced		AN3-CA: 44.7;BJ hTERT+: 53.4;RH-30: 95.7
GPR137B	TM7SF1	ENSG00000077585	G protein-coupled receptor 137B	1	236142505-236221865	Predicted membrane proteins, Transporters	Evidence at protein level	HPA026422	Approved				Colorectal cancer:1.63e-4 (unfavourable)	Expressed in all	Mixed			kidney: 70.7	Cell line enhanced		SK-MEL-30: 165.8
GOLGA2	GM130, golgin-95	ENSG00000167110	Golgin A2	9	128255829-128275995	Predicted intracellular proteins	Evidence at protein level	CAB015421, HPA021178, HPA021230, HPA021799	Enhanced		Enhanced	Golgi apparatus	Renal cancer:9.77e-5 (favourable), Colorectal cancer:1.64e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 161.0	Expressed in all		
CRY2		ENSG00000121671	Cryptochrome circadian clock 2	11	45847118-45883248	Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA037577	Supported		Supported	Nuclear speckles<br>Cytosol	Renal cancer:6.44e-15 (favourable), Liver cancer:6.82e-5 (favourable), Colorectal cancer:1.67e-4 (unfavourable), Pancreatic cancer:4.39e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 56.2	Expressed in all		
DEF6	IBP, SLAT, SWAP70L	ENSG00000023892	DEF6, guanine nucleotide exchange factor	6	35297852-35321771	Predicted intracellular proteins	Evidence at protein level	HPA038975, HPA038976	Enhanced		Enhanced	Nucleoplasm	Renal cancer:1.02e-8 (unfavourable), Breast cancer:3.02e-6 (favourable), Cervical cancer:1.08e-4 (favourable), Colorectal cancer:1.71e-4 (unfavourable), Endometrial cancer:2.37e-4 (favourable)	Expressed in all	Mixed			lymph node: 56.1	Cell line enhanced		U-937: 93.5
WBSCR27		ENSG00000165171	Williams Beuren syndrome chromosome region 27	7	73834590-73842535	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA022420	Uncertain		Supported	Focal adhesion sites	Renal cancer:1.10e-6 (favourable), Colorectal cancer:1.73e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 8.4	Cell line enhanced		RPMI-8226: 54.9;T-47d: 21.0
FAM219B	C15orf17, FLJ00005	ENSG00000178761	Family with sequence similarity 219 member B	15	74899987-74907121	Predicted intracellular proteins	Evidence at protein level	HPA048929, HPA058064	Approved		Approved	Nucleoplasm<br>Golgi apparatus	Renal cancer:1.29e-4 (favourable), Colorectal cancer:1.75e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 20.8	Mixed		
FAM3A	2-19, DXS560S, XAP-7	ENSG00000071889	Family with sequence similarity 3 member A	X	154506159-154516242	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	CAB025016, HPA056991	Uncertain		Approved	Nucleus<br>Nucleoli	Colorectal cancer:1.76e-4 (unfavourable)	Expressed in all	Expressed in all			small intestine: 28.3	Expressed in all		
CCM2	C7orf22, MGC4607, OSM	ENSG00000136280	CCM2 scaffolding protein	7	44999475-45076469	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA020273, HPA021669, HPA065815	Enhanced		Enhanced	Mitochondria	Renal cancer:5.06e-7 (unfavourable), Pancreatic cancer:1.16e-4 (favourable), Colorectal cancer:1.79e-4 (unfavourable), Glioma:3.77e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 49.1	Expressed in all		
RHOG	ARHG, MGC125835, MGC125836, RhoG	ENSG00000177105	Ras homolog family member G	11	3826978-3840983	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA039871	Enhanced				Renal cancer:9.49e-8 (unfavourable), Colorectal cancer:1.81e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 170.5	Expressed in all		
ADAMTSL4	DKFZP434K1772, TSRC1	ENSG00000143382	ADAMTS like 4	1	150549369-150560937	Disease related genes, Predicted secreted proteins	Evidence at protein level	HPA006279	Approved		Approved	Plasma membrane<br>Cytosol	Renal cancer:4.35e-7 (unfavourable), Glioma:1.63e-4 (unfavourable), Colorectal cancer:1.86e-4 (unfavourable)	Expressed in all	Tissue enhanced		placenta: 88.9	lung: 32.3	Cell line enhanced		ASC TERT1: 64.0;BEWO: 191.0;K-562: 60.1
DVL3	KIAA0208	ENSG00000161202	Dishevelled segment polarity protein 3	3	184155388-184173610	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Evidence at protein level	CAB046486, HPA058265	Approved		Approved	Intermediate filaments<br>Midbody ring<br>Centrosome	Renal cancer:1.53e-8 (unfavourable), Prostate cancer:4.77e-5 (unfavourable), Colorectal cancer:1.90e-4 (unfavourable), Liver cancer:8.41e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 55.3	Expressed in all		
SPOCK1	SPOCK, testican-1, TIC1	ENSG00000152377	SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1	5	136975298-137598379	Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA007450, HPA026770	Uncertain		Approved	Vesicles	Head and neck cancer:1.93e-5 (unfavourable), Renal cancer:3.77e-5 (unfavourable), Colorectal cancer:1.93e-4 (unfavourable), Ovarian cancer:4.72e-4 (unfavourable), Lung cancer:9.08e-4 (unfavourable), Stomach cancer:9.40e-4 (unfavourable)	Tissue enriched	Tissue enhanced		cerebral cortex: 209.2	prostate: 108.0	Cell line enhanced		AF22: 299.3;ASC diff: 403.2;HUVEC TERT2: 508.1;U-138 MG: 298.1
AIP	ARA9, FKBP16, XAP2	ENSG00000110711	Aryl hydrocarbon receptor interacting protein	11	67483041-67491103	Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB033674, HPA050217, CAB069477	Approved		Supported	Cytosol	Colorectal cancer:1.93e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 100.6	Expressed in all		
NR1D1	ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL	ENSG00000126368	Nuclear receptor subfamily 1 group D member 1	17	40092787-40100725	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA007935	Uncertain		Supported	Nuclear bodies	Melanoma:1.36e-4 (favourable), Colorectal cancer:1.94e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 37.4	Expressed in all		
TIMP1	CLGI, EPO, TIMP	ENSG00000102265	TIMP metallopeptidase inhibitor 1	X	47582313-47586789	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB022360, HPA053417	Approved		Approved	Golgi apparatus	Renal cancer:2.90e-11 (unfavourable), Colorectal cancer:2.09e-4 (unfavourable)	Expressed in all	Expressed in all			appendix: 2036.7	Expressed in all		
RNF32	FKSG33, HSD15, LMBR2	ENSG00000105982	Ring finger protein 32	7	156640281-156677130	Predicted intracellular proteins	Evidence at protein level	HPA073560	Enhanced				Colorectal cancer:2.21e-4 (unfavourable)	Mixed	Tissue enriched	8	testis: 110.5	epididymis: 13.4	Cell line enhanced		HDLM-2: 12.4
PNMA5	KIAA1934	ENSG00000198883	Paraneoplastic Ma antigen family member 5	X	152988824-152994127	Predicted intracellular proteins	Evidence at protein level	HPA044690	Enhanced				Colorectal cancer:2.25e-4 (unfavourable), Lung cancer:3.16e-4 (favourable)	Mixed	Group enriched	20	cerebral cortex: 8.1;testis: 16.3	skin,spleen: 0.5	Group enriched	495	HMC-1: 311.7;U-266/70: 426.0;U-266/84: 249.2
ANKRD39	MGC41816	ENSG00000213337	Ankyrin repeat domain 39	2	96836611-96858095	Predicted intracellular proteins	Evidence at protein level	HPA042678	Approved		Approved	Nucleoplasm<br>Vesicles	Renal cancer:6.78e-9 (unfavourable), Pancreatic cancer:6.12e-5 (favourable), Colorectal cancer:2.26e-4 (unfavourable), Urothelial cancer:5.21e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 17.2	Expressed in all		
BCAM	CD239, LU	ENSG00000187244	Basal cell adhesion molecule (Lutheran blood group)	19	44809059-44821420	Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	HPA005654	Uncertain		Approved	Nucleoli fibrillar center	Renal cancer:5.94e-6 (favourable), Endometrial cancer:1.24e-5 (unfavourable), Colorectal cancer:2.31e-4 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 174.7	Cell line enhanced		HaCaT: 278.4;SK-BR-3: 217.2;T-47d: 152.4
PTGES	MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12	ENSG00000148344	Prostaglandin E synthase	9	129738331-129753047	Enzymes, Predicted membrane proteins	Evidence at protein level	HPA045064	Enhanced		Supported	Endoplasmic reticulum	Pancreatic cancer:7.97e-5 (unfavourable), Colorectal cancer:2.32e-4 (unfavourable)	Expressed in all	Tissue enhanced		placenta: 82.9;seminal vesicle: 119.5	urinary bladder: 36.3	Cell line enhanced		BEWO: 155.0;HaCaT: 189.3;U-2197: 372.3
KRTAP5-1	KRN1L, KRTAP5.1	ENSG00000205869	Keratin associated protein 5-1	11	1584342-1585283	Predicted intracellular proteins	Evidence at transcript level						Colorectal cancer:2.37e-4 (unfavourable)	Mixed	Not detected			adrenal gland,cerebral cortex,pancreas,salivary gland,small intestine,spleen,stomach: 0.1	Cell line enhanced		SCLC-21H: 1.6
TNS1	DKFZp586K0617, MXRA6, PPP1R155, TNS	ENSG00000079308	Tensin 1	2	217799789-218002995	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB018774, HPA036089, HPA036090	Approved		Enhanced	Focal adhesion sites	Colorectal cancer:2.41e-4 (unfavourable), Urothelial cancer:5.19e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 319.5	Cell line enhanced		ASC diff: 102.7;fHDF/TERT166: 59.1;REH: 80.9
THBS3		ENSG00000169231	Thrombospondin 3	1	155195588-155209051	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA006293, HPA073242	Approved		Approved	Vesicles	Renal cancer:2.38e-12 (unfavourable), Endometrial cancer:1.44e-4 (unfavourable), Colorectal cancer:2.43e-4 (unfavourable)	Expressed in all	Expressed in all			smooth muscle: 41.6	Cell line enhanced		SCLC-21H: 49.1
CHD3	Mi-2a, Mi2-ALPHA, ZFH	ENSG00000170004	Chromodomain helicase DNA binding protein 3	17	7884806-7912760	Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA043368, HPA076524	Supported		Approved	Nucleus<br>Nucleoli<br>Microtubule organizing center	Endometrial cancer:7.68e-5 (favourable), Colorectal cancer:2.43e-4 (unfavourable), Pancreatic cancer:8.36e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 85.1	Expressed in all		
CTSD	CLN10, CPSD	ENSG00000117984	Cathepsin D	11	1752752-1764573	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB000109, HPA003001	Enhanced				Renal cancer:4.93e-5 (favourable), Colorectal cancer:2.46e-4 (unfavourable)	Expressed in all	Expressed in all			lung: 1026.9	Expressed in all		
USP20	KIAA1003	ENSG00000136878	Ubiquitin specific peptidase 20	9	129834698-129881838	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA006287, HPA007008	Uncertain	Approved	Approved	Nucleus<br>Plasma membrane<br>Cytosol	Pancreatic cancer:1.54e-7 (favourable), Renal cancer:5.65e-5 (favourable), Colorectal cancer:2.48e-4 (unfavourable), Endometrial cancer:4.01e-4 (favourable), Cervical cancer:8.01e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 22.1	Expressed in all		
CUL9	H7AP1, KIAA0708, PARC	ENSG00000112659	Cullin 9	6	43182175-43224587	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA016434, HPA052004	Approved		Approved	Cytosol	Head and neck cancer:2.37e-5 (favourable), Colorectal cancer:2.48e-4 (unfavourable), Urothelial cancer:4.87e-4 (favourable), Breast cancer:5.28e-4 (favourable), Pancreatic cancer:8.07e-4 (favourable)	Expressed in all	Mixed			testis: 10.0	Mixed		
RBP7	CRBPIV	ENSG00000162444	Retinol binding protein 7	1	9997206-10016020	Predicted intracellular proteins	Evidence at protein level	HPA034749	Enhanced		Uncertain	Nuclear speckles<br>Cytosol	Colorectal cancer:2.49e-4 (unfavourable)	Expressed in all	Tissue enhanced		adipose tissue: 260.1	breast: 82.2	Cell line enhanced		EFO-21: 12.5;SK-MEL-30: 7.2;T-47d: 32.2
TAOK2	KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2	ENSG00000149930	TAO kinase 2	16	29973641-29992261	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA010650	Approved		Supported	Nucleus<br>Nucleoli<br>Cytosol	Endometrial cancer:3.87e-5 (favourable), Colorectal cancer:2.51e-4 (unfavourable), Renal cancer:3.66e-4 (favourable), Pancreatic cancer:4.78e-4 (favourable)	Expressed in all	Expressed in all			testis: 36.9	Expressed in all		
SLC39A13	FLJ25785	ENSG00000165915	Solute carrier family 39 member 13	11	47407132-47416501	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Evidence at protein level	HPA043971	Approved		Uncertain	Cytosol	Ovarian cancer:2.73e-5 (unfavourable), Renal cancer:1.96e-4 (favourable), Colorectal cancer:2.60e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 58.3	Expressed in all		
TPM2	AMCD1, DA1, NEM4	ENSG00000198467	Tropomyosin 2 (beta)	9	35681992-35691020	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA047089, HPA053624	Approved				Renal cancer:8.51e-10 (unfavourable), Colorectal cancer:2.64e-4 (unfavourable)	Expressed in all	Tissue enriched	6	skeletal muscle: 13466.0	smooth muscle: 2282.0	Cell line enhanced		BJ: 1627.6
TSC22D4	THG-1, TILZ2	ENSG00000166925	TSC22 domain family member 4	7	100463359-100479279	Predicted intracellular proteins, Predicted secreted proteins, Transcription factors	Evidence at protein level	HPA006757	Uncertain		Approved	Cytosol	Colorectal cancer:2.66e-4 (unfavourable), Liver cancer:9.45e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 278.2	Expressed in all		
PBXIP1	HPIP	ENSG00000163346	PBX homeobox interacting protein 1	1	154944076-154956123	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA006949	Approved		Approved	Vesicles<br>Cytosol	Renal cancer:9.22e-6 (favourable), Pancreatic cancer:2.64e-4 (favourable), Colorectal cancer:2.73e-4 (unfavourable), Head and neck cancer:7.19e-4 (favourable), Lung cancer:8.99e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 138.8	Cell line enriched	7	Karpas-707: 788.8
KDM4B	JMJD2B, KIAA0876, TDRD14B	ENSG00000127663	Lysine demethylase 4B	19	4969113-5153595	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA062872			Supported	Nucleus<br>Cytosol	Endometrial cancer:4.25e-7 (favourable), Melanoma:2.13e-4 (unfavourable), Colorectal cancer:2.74e-4 (unfavourable), Breast cancer:7.39e-4 (favourable)	Expressed in all	Expressed in all			thyroid gland: 19.9	Expressed in all		
SERPINE1	PAI, PAI1, PLANH1	ENSG00000106366	Serpin family E member 1	7	101127089-101139266	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Evidence at protein level	HPA050039, CAB068501	Uncertain		Approved	Cytosol	Renal cancer:5.88e-8 (unfavourable), Stomach cancer:3.27e-6 (unfavourable), Lung cancer:4.41e-6 (unfavourable), Head and neck cancer:2.84e-5 (unfavourable), Colorectal cancer:2.82e-4 (unfavourable), Cervical cancer:5.01e-4 (unfavourable), Urothelial cancer:5.51e-4 (unfavourable)	Expressed in all	Tissue enhanced		gallbladder: 580.3;placenta: 600.2	adipose tissue: 215.8	Cell line enhanced		TIME: 8072.1;U-138 MG: 4492.2;U-251 MG: 3465.4
RNF187		ENSG00000168159	Ring finger protein 187	1	228487061-228495766	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA030098	Approved		Supported	Nucleoplasm<br>Cytosol	Colorectal cancer:2.83e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 143.2	Expressed in all		
AFAP1L1	FLJ36748	ENSG00000157510	Actin filament associated protein 1 like 1	5	149271871-149341802	Predicted intracellular proteins	Evidence at protein level						Colorectal cancer:2.84e-4 (unfavourable)	Expressed in all	Mixed			adipose tissue: 29.8	Cell line enhanced		BEWO: 57.1;TIME: 37.4;WM-115: 105.1
MIER2	KIAA1193	ENSG00000105556	MIER family member 2	19	301444-344815	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA041439	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:7.22e-6 (unfavourable), Endometrial cancer:1.72e-5 (favourable), Colorectal cancer:2.89e-4 (unfavourable)	Expressed in all	Mixed			testis: 12.8	Mixed		
HIST2H2BE	H2B, H2B.1, H2B/q, H2BFQ	ENSG00000184678	Histone cluster 2 H2B family member e	1	149884459-149886652	Predicted intracellular proteins	Evidence at protein level	HPA042205, HPA043013, HPA048671	Supported		Approved	Nucleoplasm<br>Cytosol	Colorectal cancer:2.90e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 113.5	Cell line enhanced		Karpas-707: 40.8;U-266/70: 71.4
PRNP	AltPrP, CD230, CJD, GSS, PRIP, PRP	ENSG00000171867	Prion protein	20	4686236-4701590	CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters	Evidence at protein level	HPA042754, HPA043398	Enhanced		Approved	Nuclear membrane<br>Vesicles<br>Cytosol	Liver cancer:7.41e-5 (unfavourable), Glioma:1.99e-4 (unfavourable), Colorectal cancer:2.96e-4 (unfavourable), Endometrial cancer:4.64e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 619.4	Cell line enhanced		WM-115: 985.1
C8G		ENSG00000176919	Complement C8 gamma chain	9	136945246-136946974	Plasma proteins, Predicted secreted proteins	Evidence at protein level	HPA046269	Approved		Uncertain	Endoplasmic reticulum	Colorectal cancer:2.99e-4 (unfavourable)	Tissue enriched	Group enriched	6	duodenum: 49.8;liver: 106.5;small intestine: 34.5	gallbladder: 9.8	Cell line enriched	16	HMC-1: 139.2
FSTL3	FLRG, FSRP	ENSG00000070404	Follistatin like 3	19	676365-683399	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB024899, HPA045378	Approved		Approved	Nucleoplasm	Lung cancer:4.61e-7 (unfavourable), Ovarian cancer:1.65e-4 (unfavourable), Colorectal cancer:3.01e-4 (unfavourable), Endometrial cancer:3.03e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 260.8	Expressed in all		
OLFM2	NOE2, OlfC	ENSG00000105088	Olfactomedin 2	19	9853718-9936552	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA049961, HPA057771	Uncertain		Approved	Nucleoplasm	Renal cancer:2.21e-4 (unfavourable), Colorectal cancer:3.05e-4 (unfavourable)	Expressed in all	Tissue enhanced		cerebral cortex: 124.0;skin: 111.2	adipose tissue: 36.8	Cell line enhanced		AN3-CA: 23.7;SH-SY5Y: 25.7;U-2 OS: 30.2;WM-115: 25.2
MEGF6	EGFL3	ENSG00000162591	Multiple EGF like domains 6	1	3489920-3611495	Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA052129	Uncertain		Approved	Microtubules<br>Cytokinetic bridge	Colorectal cancer:3.08e-4 (unfavourable), Head and neck cancer:6.57e-4 (favourable)	Expressed in all	Tissue enhanced		skin: 48.2	gallbladder: 17.0	Cell line enhanced		BJ: 37.3;HeLa: 26.6;U-2197: 36.2
DNAJC4	HSPF2, MCG18	ENSG00000110011	DnaJ heat shock protein family (Hsp40) member C4	11	64230278-64234286	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA011947	Uncertain				Colorectal cancer:3.12e-4 (unfavourable), Renal cancer:6.21e-4 (favourable)	Expressed in all	Expressed in all			testis: 136.6	Expressed in all		
IDUA	MPS1	ENSG00000127415	Iduronidase, alpha-L-	4	986997-1004506	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB025901, HPA046979, HPA054254	Enhanced		Supported	Vesicles	Renal cancer:7.87e-5 (unfavourable), Urothelial cancer:8.04e-5 (favourable), Colorectal cancer:3.13e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 16.5	Cell line enhanced		U-266/70: 43.1
PPP2R2D	MDS026	ENSG00000175470	Protein phosphatase 2 regulatory subunit Bdelta	10	131900644-131959834	Predicted intracellular proteins	Evidence at protein level	HPA042122, HPA042770	Approved		Approved	Cytosol	Colorectal cancer:3.14e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 6.7	Mixed		
TSPYL2	CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX	ENSG00000184205	TSPY like 2	X	53082367-53088540	Predicted intracellular proteins	Evidence at protein level	HPA044133	Approved				Pancreatic cancer:6.74e-8 (favourable), Renal cancer:8.16e-7 (unfavourable), Colorectal cancer:3.23e-4 (unfavourable)	Expressed in all	Expressed in all			ovary: 144.3	Expressed in all		
PLOD3	LH3	ENSG00000106397	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	7	101205977-101218420	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA001236	Uncertain				Cervical cancer:1.91e-5 (unfavourable), Colorectal cancer:3.26e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 48.1	Expressed in all		
PARP6	pART17	ENSG00000137817	Poly(ADP-ribose) polymerase family member 6	15	72241181-72272999	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA026991	Approved		Approved	Plasma membrane	Renal cancer:8.02e-8 (unfavourable), Cervical cancer:3.17e-5 (favourable), Colorectal cancer:3.37e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 46.9	Mixed		
NUMBL	CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23	ENSG00000105245	NUMB like, endocytic adaptor protein	19	40665905-40690972	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA058251, HPA058380	Approved				Renal cancer:7.55e-15 (unfavourable), Ovarian cancer:1.52e-4 (unfavourable), Colorectal cancer:3.49e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 41.7	Expressed in all		
AKAP8L	HAP95, NAKAP95	ENSG00000011243	A-kinase anchoring protein 8 like	19	15380048-15419141	Predicted intracellular proteins	Evidence at protein level	HPA042485, HPA042546	Enhanced		Supported	Nuclear speckles	Renal cancer:1.08e-7 (unfavourable), Colorectal cancer:3.49e-4 (unfavourable), Pancreatic cancer:8.04e-4 (favourable)	Expressed in all	Expressed in all			testis: 41.6	Expressed in all		
PLEKHG2	ARHGEF42, CLG, FLJ00018	ENSG00000090924	Pleckstrin homology and RhoGEF domain containing G2	19	39412585-39428415	Predicted intracellular proteins	Evidence at protein level	HPA017973, HPA048054	Uncertain		Approved	Nucleoplasm<br>Cytosol	Renal cancer:3.79e-8 (unfavourable), Colorectal cancer:3.53e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 33.2	Expressed in all		
FOXC1	ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1	ENSG00000054598	Forkhead box C1	6	1609972-1613897	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA040670	Enhanced		Supported	Nucleoplasm<br>Cytosol	Colorectal cancer:3.53e-4 (unfavourable)	Expressed in all	Tissue enhanced		salivary gland: 66.2	kidney: 21.8	Cell line enhanced		AN3-CA: 86.7;HEK 293: 85.3
TRIP10	CIP4, HSTP, STOT, STP	ENSG00000125733	Thyroid hormone receptor interactor 10	19	6737925-6751526	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA041934, HPA072625, HPA073886	Approved		Supported	Nucleoplasm<br>Vesicles	Head and neck cancer:1.76e-4 (favourable), Colorectal cancer:3.61e-4 (unfavourable), Renal cancer:4.66e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 129.0	Mixed		
PXDC1	C6orf145	ENSG00000168994	PX domain containing 1	6	3722614-3752026	Predicted intracellular proteins	Evidence at protein level	HPA019246			Approved	Plasma membrane	Endometrial cancer:1.14e-4 (unfavourable), Colorectal cancer:3.64e-4 (unfavourable)	Expressed in all	Mixed			placenta: 82.7	Mixed		
TMPRSS3	DFNB10, DFNB8	ENSG00000160183	Transmembrane protease, serine 3	21	42371890-42396846	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Evidence at protein level						Colorectal cancer:3.64e-4 (unfavourable), Renal cancer:8.24e-4 (unfavourable)	Mixed	Tissue enhanced		fallopian tube: 35.2	stomach: 13.7	Cell line enhanced		HEL: 58.2;SiHa: 35.3;U-266/84: 182.5
PRKRIP1	C114, FLJ13902, KRBOX3	ENSG00000128563	PRKR interacting protein 1 (IL11 inducible)	7	102363872-102426676	Predicted intracellular proteins	Evidence at protein level	HPA051146	Uncertain		Supported	Actin filaments<br>Cytosol	Urothelial cancer:1.94e-4 (favourable), Colorectal cancer:3.65e-4 (unfavourable), Renal cancer:4.39e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 34.7	Expressed in all		
AOC3	HPAO, VAP-1, VAP1	ENSG00000131471	Amine oxidase, copper containing 3	17	42851184-42858130	Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA000980, CAB025797	Enhanced		Approved	Golgi apparatus<br>Cytosol	Renal cancer:1.79e-5 (unfavourable), Colorectal cancer:3.68e-4 (unfavourable), Urothelial cancer:6.98e-4 (unfavourable)	Expressed in all	Tissue enhanced		adipose tissue: 450.1	smooth muscle: 205.7	Cell line enriched	17	ASC diff: 210.1
SCT		ENSG00000070031	Secretin	11	626431-627143	Predicted secreted proteins	Evidence at protein level	HPA050961	Enhanced				Colorectal cancer:3.70e-4 (unfavourable)	Mixed	Group enriched	6	duodenum: 34.9;small intestine: 7.8	spleen: 3.4	Cell line enhanced		HSkMC: 1.1
CBX7		ENSG00000100307	Chromobox 7	22	39120167-39152674	Predicted intracellular proteins	Evidence at protein level	CAB011574, HPA048677, HPA056480	Enhanced		Supported	Nucleoplasm<br>Cytosol	Renal cancer:2.45e-5 (favourable), Pancreatic cancer:1.04e-4 (favourable), Cervical cancer:3.63e-4 (favourable), Colorectal cancer:3.73e-4 (unfavourable), Breast cancer:6.18e-4 (favourable)	Expressed in all	Expressed in all			seminal vesicle: 81.6	Cell line enhanced		HDLM-2: 34.6
LMNTD2	C11orf35, MGC35138	ENSG00000185522	Lamin tail domain containing 2	11	554855-560779	Predicted intracellular proteins	Evidence at protein level	HPA058474, HPA073912	Uncertain		Approved	Cytoplasmic bodies	Colorectal cancer:3.75e-4 (unfavourable)	Mixed	Mixed			thyroid gland: 9.4	Cell line enhanced		AN3-CA: 4.1;T-47d: 4.6
CLK2	clk2	ENSG00000176444	CDC like kinase 2	1	155262868-155278491	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA055366, HPA059507	Approved		Enhanced	Nucleoplasm<br>Nuclear bodies	Renal cancer:2.95e-9 (unfavourable), Liver cancer:2.82e-4 (unfavourable), Colorectal cancer:3.77e-4 (unfavourable), Urothelial cancer:5.43e-4 (favourable)	Expressed in all	Expressed in all			parathyroid gland: 26.8	Expressed in all		
PABPC1L	C20orf119, dJ1069P2.3, ePAB, PABPC1L1	ENSG00000101104	Poly(A) binding protein cytoplasmic 1 like	20	44910062-44959035	Predicted intracellular proteins	Evidence at protein level	HPA066650			Approved	Nuclear bodies<br>Cytosol	Renal cancer:4.00e-15 (unfavourable), Colorectal cancer:3.80e-4 (unfavourable), Urothelial cancer:8.84e-4 (favourable)	Expressed in all	Mixed			thyroid gland: 54.1	Expressed in all		
HIST1H2BD	H2B/b, H2BFB	ENSG00000158373	Histone cluster 1 H2B family member d	6	26158146-26171349	Predicted intracellular proteins	Evidence at protein level	HPA042205, HPA043013, HPA048671, CAB062336	Supported		Approved	Nucleoplasm<br>Cytosol	Colorectal cancer:3.84e-4 (unfavourable)	Expressed in all	Expressed in all			prostate: 90.2	Expressed in all		
NFKB2	LYT-10, NF-kB2, p105, p49/p100, p52	ENSG00000077150	Nuclear factor kappa B subunit 2	10	102394110-102402529	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA008422, CAB022098, HPA023900	Enhanced		Approved	Nucleoplasm<br>Cytosol	Renal cancer:6.69e-12 (unfavourable), Melanoma:8.45e-5 (favourable), Colorectal cancer:3.86e-4 (unfavourable)	Expressed in all	Expressed in all			appendix: 70.7	Expressed in all		
PPP1R26	KIAA0649	ENSG00000196422	Protein phosphatase 1 regulatory subunit 26	9	135479079-135488893	Predicted intracellular proteins	Evidence at protein level	HPA044686, HPA063817	Uncertain		Enhanced	Nucleoplasm	Renal cancer:6.20e-13 (favourable), Colorectal cancer:3.98e-4 (unfavourable), Pancreatic cancer:6.93e-4 (favourable), Endometrial cancer:9.91e-4 (favourable)	Expressed in all	Mixed			parathyroid gland: 27.6	Mixed		
SPARCL1	MAST9	ENSG00000152583	SPARC like 1	4	87473335-87531061	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB026225	Enhanced				Urothelial cancer:3.33e-4 (unfavourable), Colorectal cancer:4.06e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 2035.8	Cell line enhanced		AF22: 23.6;U-266/70: 7.1
PLEC	EBS1, PCN, PLEC1, PLTN	ENSG00000178209	Plectin	8	143915147-143976734	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB003847, HPA025967, HPA029906	Enhanced		Enhanced	Intermediate filaments<br>Focal adhesion sites<br>Cytosol	Renal cancer:7.98e-6 (unfavourable), Colorectal cancer:4.29e-4 (unfavourable), Lung cancer:5.33e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 94.8	Expressed in all		
EPHB4	HTK, Tyro11	ENSG00000196411	EPH receptor B4	7	100802565-100827521	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	CAB013537	Uncertain				Colorectal cancer:4.33e-4 (unfavourable), Breast cancer:8.56e-4 (unfavourable), Urothelial cancer:8.84e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 50.6	Mixed		
ENDOV	FLJ35220	ENSG00000173818	Endonuclease V	17	80415165-80438086	Predicted intracellular proteins	Evidence at protein level						Breast cancer:4.24e-5 (favourable), Colorectal cancer:4.40e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 22.2	Mixed		
EPS8L1	DRC3, FLJ20258, MGC23164, MGC4642	ENSG00000131037	EPS8 like 1	19	55072020-55087923	Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA041851, HPA043545	Uncertain		Supported	Cytosol	Colorectal cancer:4.44e-4 (unfavourable)	Mixed	Tissue enhanced		skin: 18.4;stomach: 23.5	esophagus: 9.0	Cell line enhanced		BEWO: 51.9;T-47d: 24.8
TNFRSF25	APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR	ENSG00000215788	TNF receptor superfamily member 25	1	6461151-6466195	Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level	HPA069834			Approved	Nucleus<br>Plasma membrane<br>Actin filaments<br>Focal adhesion sites	Renal cancer:1.65e-7 (unfavourable), Head and neck cancer:3.09e-4 (favourable), Colorectal cancer:4.46e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 29.6	spleen: 12.1	Cell line enhanced		HDLM-2: 24.6;RPMI-8226: 17.9
PCGF2	MEL-18, RNF110, ZNF144	ENSG00000277258	Polycomb group ring finger 2	17	38733897-38749817	Predicted intracellular proteins	Evidence at protein level	HPA047732, HPA063531	Uncertain		Supported	Nucleus	Colorectal cancer:4.55e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 20.1	Mixed		
SHC2	SCK, SHCB, SLI	ENSG00000129946	SHC adaptor protein 2	19	416583-460996	Predicted intracellular proteins, RAS pathway related proteins	Evidence at protein level	HPA006136	Approved		Approved	Cytosol	Colorectal cancer:4.58e-4 (unfavourable), Pancreatic cancer:8.53e-4 (favourable)	Expressed in all	Mixed			cerebral cortex: 18.7	Cell line enhanced		SCLC-21H: 14.8;SH-SY5Y: 12.0
TNNT1	ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS	ENSG00000105048	Troponin T1, slow skeletal type	19	55132794-55149354	Disease related genes, Predicted intracellular proteins	Evidence at protein level	CAB015168, HPA058448	Enhanced		Approved	Nucleus<br>Golgi apparatus<br>Cytosol	Renal cancer:0.00e+0 (unfavourable), Pancreatic cancer:2.53e-4 (unfavourable), Colorectal cancer:4.66e-4 (unfavourable), Endometrial cancer:4.66e-4 (unfavourable)	Expressed in all	Tissue enriched	12	skeletal muscle: 7568.7	esophagus: 632.9	Cell line enhanced		HMC-1: 728.7;RH-30: 606.8
PPP1R18	KIAA1949, phostensin	ENSG00000146112	Protein phosphatase 1 regulatory subunit 18	6	30676389-30687895	Predicted intracellular proteins	Evidence at protein level	HPA044745, HPA051000	Enhanced		Approved	Nucleoplasm<br>Plasma membrane	Renal cancer:1.11e-16 (unfavourable), Colorectal cancer:4.71e-4 (unfavourable)	Expressed in all	Tissue enhanced		lymph node: 53.3	spleen: 35.1	Mixed		
FASTK	FAST	ENSG00000164896	Fas activated serine/threonine kinase	7	151076593-151080866	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA031621, CAB032539	Approved		Approved	Nuclear speckles<br>Mitochondria	Pancreatic cancer:3.99e-4 (favourable), Colorectal cancer:4.73e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 41.7	Expressed in all		
SNAI1	SLUGH2, SNA, SNAH, SNAIL, SNAIL1	ENSG00000124216	Snail family transcriptional repressor 1	20	49982999-49988886	Predicted intracellular proteins, Transcription factors	Evidence at protein level	CAB005883, HPA056831, HPA069985, CAB078687	Supported		Supported	Nucleus<br>Cytosol	Renal cancer:2.63e-7 (unfavourable), Thyroid cancer:8.82e-7 (unfavourable), Lung cancer:1.61e-5 (unfavourable), Colorectal cancer:4.76e-4 (unfavourable)	Expressed in all	Tissue enhanced		gallbladder: 26.2	thyroid gland: 13.4	Cell line enhanced		SiHa: 30.1;TIME: 32.4;WM-115: 25.0
DNAJB12	DJ10, FLJ20027	ENSG00000148719	DnaJ heat shock protein family (Hsp40) member B12	10	72332830-72355230	Predicted membrane proteins	Evidence at protein level	HPA010642	Approved		Supported	Endoplasmic reticulum	Colorectal cancer:4.79e-4 (unfavourable), Head and neck cancer:8.17e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 48.0	Expressed in all		
HYI	HT036	ENSG00000178922	Hydroxypyruvate isomerase (putative)	1	43451003-43453989	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA040092	Uncertain		Approved	Golgi apparatus<br>Plasma membrane<br>Cytosol	Urothelial cancer:2.72e-5 (favourable), Renal cancer:2.75e-5 (unfavourable), Colorectal cancer:4.96e-4 (unfavourable), Liver cancer:5.55e-4 (unfavourable), Breast cancer:9.18e-4 (favourable)	Expressed in all	Expressed in all			seminal vesicle: 81.4	Mixed		
ADAMTSL2	KIAA0605	ENSG00000197859	ADAMTS like 2	9	133532164-133575519	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA045634, HPA053812	Approved		Approved	Vesicles	Colorectal cancer:5.01e-4 (unfavourable), Pancreatic cancer:6.70e-4 (favourable)	Expressed in all	Tissue enhanced		adrenal gland: 29.0	kidney: 11.2	Cell line enhanced		Hep G2: 4.9;RPMI-8226: 6.9;SH-SY5Y: 31.9
MFNG		ENSG00000100060	MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	22	37469063-37486401	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA048936, HPA056479	Approved		Uncertain	Actin filaments	Renal cancer:3.31e-5 (unfavourable), Endometrial cancer:1.65e-4 (favourable), Colorectal cancer:5.12e-4 (unfavourable)	Expressed in all	Mixed			lymph node: 68.5	Cell line enhanced		HL-60: 153.4;HMC-1: 213.3;HUVEC TERT2: 166.4;U-937: 134.0
TFPT	amida, FB1, INO80F	ENSG00000105619	TCF3 fusion partner	19	54107013-54115675	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA034958, HPA058534	Approved		Supported	Nucleoplasm<br>Nuclear membrane	Pancreatic cancer:3.13e-4 (favourable), Colorectal cancer:5.13e-4 (unfavourable), Liver cancer:5.25e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 10.6	Mixed		
ZNF385A	DKFZp586G1122, Hzf, ZFP385, ZNF385	ENSG00000161642	Zinc finger protein 385A	12	54369133-54391298	Predicted intracellular proteins	Evidence at protein level	HPA039799			Supported	Nucleus<br>Cytosol	Renal cancer:9.75e-5 (unfavourable), Colorectal cancer:5.20e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 170.0	cerebral cortex: 66.1	Cell line enhanced		HEL: 98.3
ADAP1	CENTA1, GCS1L	ENSG00000105963	ArfGAP with dual PH domains 1	7	897901-955407	Predicted intracellular proteins	Evidence at protein level	HPA007033, HPA012049	Enhanced		Supported	Plasma membrane<br>Cytosol	Renal cancer:4.13e-5 (favourable), Colorectal cancer:5.25e-4 (unfavourable), Head and neck cancer:9.13e-4 (unfavourable)	Expressed in all	Tissue enhanced		cerebral cortex: 80.4	colon: 37.9	Cell line enhanced		A-431: 97.9;CAPAN-2: 69.1;HMC-1: 64.7;THP-1: 87.7
ABHD8	FLJ11743, MGC14280, MGC2512	ENSG00000127220	Abhydrolase domain containing 8	19	17292131-17310236	Predicted intracellular proteins	Evidence at protein level	HPA037658, HPA058209	Approved		Approved	Nucleoplasm<br>Nuclear bodies	Pancreatic cancer:3.04e-5 (favourable), Colorectal cancer:5.25e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 28.5	Cell line enhanced		PC-3: 48.7
MOGS	CWH41, DER7, GCS1	ENSG00000115275	Mannosyl-oligosaccharide glucosidase	2	74461057-74465410	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA011322, HPA011969	Approved		Enhanced	Endoplasmic reticulum	Renal cancer:2.79e-8 (unfavourable), Liver cancer:2.34e-6 (unfavourable), Colorectal cancer:5.33e-4 (unfavourable)	Expressed in all	Expressed in all			duodenum: 63.1	Expressed in all		
PTPN6	HCP, HCPH, PTP-1C, SHP-1, SHP1	ENSG00000111679	Protein tyrosine phosphatase, non-receptor type 6	12	6946468-6961316	Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA001466, CAB004572, CAB072845	Enhanced		Supported	Nucleus<br>Nucleoli	Urothelial cancer:2.64e-8 (favourable), Cervical cancer:1.87e-4 (favourable), Colorectal cancer:5.42e-4 (unfavourable), Endometrial cancer:6.65e-4 (favourable)	Expressed in all	Mixed			lymph node: 161.5	Cell line enhanced		HEL: 143.6;HMC-1: 527.9;THP-1: 163.9
GAL3ST4	FLJ12116	ENSG00000197093	Galactose-3-O-sulfotransferase 4	7	100159244-100168750	Predicted membrane proteins	Evidence at protein level	HPA038137, HPA038138	Uncertain		Approved	Nucleoplasm<br>Cytosol	Ovarian cancer:2.57e-4 (unfavourable), Renal cancer:4.14e-4 (unfavourable), Colorectal cancer:5.44e-4 (unfavourable)	Expressed in all	Tissue enhanced		skin: 32.6	smooth muscle: 14.7	Cell line enhanced		WM-115: 42.3
TMEM185B	FAM11B, FLJ20979	ENSG00000226479	Transmembrane protein 185B	2	120221278-120223408	Predicted membrane proteins	Evidence at protein level	HPA048295, HPA071744	Uncertain		Approved	Endoplasmic reticulum	Liver cancer:5.71e-7 (unfavourable), Endometrial cancer:4.96e-6 (unfavourable), Colorectal cancer:5.44e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 62.6	Mixed		
COQ10A	FLJ32452	ENSG00000135469	Coenzyme Q10A	12	56266858-56270966	Predicted intracellular proteins	Evidence at protein level	HPA068931			Approved	Endoplasmic reticulum<br>Golgi apparatus<br>Cytosol	Pancreatic cancer:2.06e-4 (favourable), Renal cancer:3.44e-4 (favourable), Colorectal cancer:5.46e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 97.2	Expressed in all		
SMARCD3	BAF60C, CRACD3, Rsc6p	ENSG00000082014	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3	7	151238764-151277896	Predicted intracellular proteins	Evidence at protein level	HPA063955, HPA065517	Uncertain		Enhanced	Nucleoplasm	Colorectal cancer:5.50e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 82.7	Cell line enhanced		AN3-CA: 63.9
UBTD1	FLJ11807	ENSG00000165886	Ubiquitin domain containing 1	10	97498868-97571209	Predicted intracellular proteins	Evidence at protein level	HPA034825	Uncertain		Approved	Vesicles<br>Plasma membrane<br>Cytosol	Colorectal cancer:5.54e-4 (unfavourable)	Expressed in all	Mixed			testis: 34.0	Mixed		
TLN1	ILWEQ, TLN	ENSG00000137076	Talin 1	9	35696948-35732395	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB002006, HPA004748	Supported		Supported	Plasma membrane<br>Focal adhesion sites<br>Microtubule organizing center<br>Cytosol	Colorectal cancer:5.56e-4 (unfavourable), Renal cancer:7.21e-4 (favourable)	Expressed in all	Expressed in all			smooth muscle: 204.8	Expressed in all		
NEXN	NELIN, nexilin	ENSG00000162614	Nexilin F-actin binding protein	1	77888513-77943895	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA011185	Approved				Colorectal cancer:5.60e-4 (unfavourable)	Mixed	Tissue enhanced		heart muscle: 298.6;skeletal muscle: 248.9	prostate: 109.6	Cell line enhanced		BJ: 129.6;LHCN-M2: 116.4;RH-30: 106.0
RGCC	bA157L14.2, C13orf15, RGC-32, RGC32	ENSG00000102760	Regulator of cell cycle	13	41457559-41470882	Predicted secreted proteins	Evidence at protein level	HPA035638, HPA063701	Approved		Supported	Nucleus<br>Nucleoli	Colorectal cancer:5.60e-4 (unfavourable)	Expressed in all	Expressed in all			lung: 409.0	Cell line enhanced		BJ hTERT+: 255.6;Daudi: 75.1;U-698: 75.7
ADAP2	CENTA2	ENSG00000184060	ArfGAP with dual PH domains 2	17	30906344-30959322	Predicted intracellular proteins	Evidence at protein level						Renal cancer:2.36e-6 (unfavourable), Liver cancer:3.12e-4 (unfavourable), Head and neck cancer:3.97e-4 (favourable), Colorectal cancer:5.62e-4 (unfavourable)	Expressed in all	Mixed			spleen: 29.3	Cell line enhanced		HAP1: 17.5;HEK 293: 9.1;RPMI-8226: 15.4
CRTC2	TORC2	ENSG00000160741	CREB regulated transcription coactivator 2	1	153947669-153958625	Predicted intracellular proteins	Evidence at protein level	HPA028454, HPA028465	Supported		Enhanced	Nucleoplasm	Renal cancer:1.35e-7 (unfavourable), Urothelial cancer:6.12e-5 (favourable), Colorectal cancer:5.75e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 36.0	Expressed in all		
FES	FPS	ENSG00000182511	FES proto-oncogene, tyrosine kinase	15	90883695-90895776	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Evidence at protein level	HPA001376	Approved		Approved	Nucleus<br>Vesicles<br>Cytosol	Colorectal cancer:5.78e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 96.5	Cell line enhanced		HEL: 56.3;HL-60: 45.0;HMC-1: 100.9;NB-4: 46.6;THP-1: 73.8
FLOT1		ENSG00000137312	Flotillin 1	6	30727709-30742733	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA001393, CAB007766	Enhanced		Approved	Golgi apparatus<br>Vesicles<br>Plasma membrane	Renal cancer:1.49e-4 (unfavourable), Ovarian cancer:3.06e-4 (favourable), Colorectal cancer:5.78e-4 (unfavourable)	Expressed in all	Expressed in all			cervix, uterine: 18.9	Expressed in all		
NFATC4	NFAT3	ENSG00000100968	Nuclear factor of activated T-cells 4	14	24365673-24379604	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA031641, CAB032859, HPA076526	Uncertain		Supported	Nuclear speckles<br>Cytosol	Renal cancer:1.81e-6 (unfavourable), Colorectal cancer:5.84e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 75.9	Cell line enhanced		BJ hTERT+: 80.5
DNAJC17	FLJ10634	ENSG00000104129	DnaJ heat shock protein family (Hsp40) member C17	15	40765155-40807478	Predicted intracellular proteins	Evidence at protein level	HPA040914, HPA041187	Approved		Approved	Nucleoplasm	Colorectal cancer:5.89e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 24.4	Expressed in all		
HSD3B7	C(27)-3BETA-HSD, SDR11E3	ENSG00000099377	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7	16	30985207-30989152	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA050521, HPA060847	Uncertain		Supported	Lipid droplets	Renal cancer:1.60e-6 (unfavourable), Colorectal cancer:5.95e-4 (unfavourable)	Expressed in all	Expressed in all			liver: 21.9	Cell line enhanced		HDLM-2: 83.9;HMC-1: 85.9;U-2197: 89.0
STK25	SOK1, YSK1	ENSG00000115694	Serine/threonine kinase 25	2	241492674-241509730	Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA047147	Uncertain				Liver cancer:3.91e-8 (unfavourable), Colorectal cancer:6.03e-4 (unfavourable)	Expressed in all	Expressed in all			skeletal muscle: 168.2	Expressed in all		
GPSM1	AGS3, DKFZP727I051	ENSG00000160360	G-protein signaling modulator 1	9	136327476-136359605	Predicted intracellular proteins	Evidence at protein level	HPA042199	Uncertain		Supported	Nucleoplasm<br>Golgi apparatus	Renal cancer:3.30e-4 (unfavourable), Colorectal cancer:6.07e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 28.4	Cell line enhanced		REH: 73.8
RAB3IL1	GRAB	ENSG00000167994	RAB3A interacting protein like 1	11	61897301-61920269	Predicted intracellular proteins	Evidence at protein level	HPA039723	Uncertain		Approved	Cytosol	Liver cancer:1.61e-7 (unfavourable), Renal cancer:1.49e-4 (unfavourable), Thyroid cancer:3.30e-4 (unfavourable), Colorectal cancer:6.08e-4 (unfavourable)	Expressed in all	Mixed			testis: 48.7	Cell line enhanced		K-562: 39.5;U-2197: 52.9
PHF21A	BHC80, BM-006, KIAA1696	ENSG00000135365	PHD finger protein 21A	11	45929323-46121178	Predicted intracellular proteins	Evidence at protein level	HPA023580	Uncertain				Renal cancer:2.59e-8 (unfavourable), Liver cancer:1.66e-6 (unfavourable), Colorectal cancer:6.15e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 43.7	Expressed in all		
GBGT1	A3GALNT, FS, MGC44848, UDP-GalNAc	ENSG00000148288	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1	9	133152948-133163945	Predicted secreted proteins	Evidence at protein level	HPA051298	Approved				Renal cancer:3.46e-5 (unfavourable), Colorectal cancer:6.22e-4 (unfavourable)	Expressed in all	Mixed			placenta: 15.6	Cell line enhanced		HEL: 53.1;HMC-1: 47.0
PTRF	cavin-1, CAVIN1	ENSG00000177469	Polymerase I and transcript release factor	17	42402452-42423517	Disease related genes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA049838, HPA074213	Supported		Supported	Vesicles<br>Plasma membrane	Urothelial cancer:5.87e-4 (unfavourable), Ovarian cancer:5.92e-4 (unfavourable), Colorectal cancer:6.36e-4 (unfavourable)	Expressed in all	Expressed in all			adipose tissue: 343.1	Cell line enhanced		BJ: 868.3;U-138 MG: 835.1
PLPPR2	LPPR2, PRG-4	ENSG00000105520	Phospholipid phosphatase related 2	19	11355386-11365698	Enzymes, Predicted membrane proteins	Evidence at protein level	HPA048973	Uncertain		Approved	Nucleoplasm	Renal cancer:7.46e-11 (unfavourable), Colorectal cancer:6.45e-4 (unfavourable), Pancreatic cancer:6.82e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 77.2	Cell line enhanced		U-2197: 88.4
MARCH2	HSPC240, MARCH-II, RNF172	ENSG00000099785	Membrane associated ring-CH-type finger 2	19	8413270-8439017	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA014063	Approved		Approved	Cytosol	Endometrial cancer:1.05e-5 (favourable), Pancreatic cancer:6.21e-4 (favourable), Colorectal cancer:6.48e-4 (unfavourable), Head and neck cancer:8.29e-4 (favourable)	Expressed in all	Expressed in all			epididymis: 64.8	Mixed		
TOR4A	C9orf167, FLJ20245	ENSG00000198113	Torsin family 4 member A	9	137277749-137282641	Predicted intracellular proteins	Evidence at protein level	HPA044913	Enhanced		Approved	Nucleoplasm	Liver cancer:3.44e-4 (unfavourable), Colorectal cancer:6.48e-4 (unfavourable)	Expressed in all	Mixed			stomach: 11.5	Mixed		
SOX13	ICA12, MGC117216, Sox-13	ENSG00000143842	SRY-box 13	1	204073115-204127743	Plasma proteins, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA051790, HPA054843			Enhanced	Nucleoplasm	Colorectal cancer:6.49e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 53.8	Cell line enhanced		SK-BR-3: 103.3
EBF4	COE4, KIAA1442, O/E-4, RP5-860F19.3	ENSG00000088881	Early B-cell factor 4	20	2692878-2760108	Predicted intracellular proteins, Transcription factors	Evidence at transcript level						Pancreatic cancer:2.47e-5 (favourable), Colorectal cancer:6.59e-4 (unfavourable)	Expressed in all	Mixed			parathyroid gland: 23.7	Cell line enhanced		SH-SY5Y: 15.8
PTOV1		ENSG00000104960	Prostate tumor overexpressed 1	19	49850735-49860744	Predicted intracellular proteins	Evidence at protein level	HPA051812, HPA075125	Approved		Supported	Nucleus	Colorectal cancer:6.64e-4 (unfavourable), Pancreatic cancer:9.20e-4 (favourable)	Expressed in all	Expressed in all			adrenal gland: 59.4	Expressed in all		
RUBCN	KIAA0226, rubicon, rundataxin	ENSG00000145016	RUN and cysteine rich domain containing beclin 1 interacting protein	3	197671393-197749727	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA050908, HPA054497	Approved		Supported	Vesicles<br>Cytosol	Liver cancer:9.91e-5 (unfavourable), Prostate cancer:1.62e-4 (unfavourable), Colorectal cancer:6.65e-4 (unfavourable)	Expressed in all	Expressed in all			spleen,testis: 24.3	Expressed in all		
TPBG	5T4, 5T4-AG	ENSG00000146242	Trophoblast glycoprotein	6	82363206-82370828	Predicted membrane proteins	Evidence at protein level	HPA010554	Enhanced		Approved	Nucleoplasm	Colorectal cancer:6.68e-4 (unfavourable)	Expressed in all	Mixed			cervix, uterine: 17.4	Cell line enhanced		hTEC/SVTERT24-B: 64.9
TBC1D8	AD3, GRAMD8, HBLP1, VRP	ENSG00000204634	TBC1 domain family member 8	2	101007617-101252866	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	CAB015211, HPA037496	Uncertain		Supported	Nucleus	Colorectal cancer:6.73e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 45.1	Cell line enhanced		ASC diff: 59.6
BCL7A	BCL7	ENSG00000110987	BCL tumor suppressor 7A	12	122019422-122062044	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA019762	Approved		Approved	Nucleoplasm<br>Vesicles	Renal cancer:1.54e-6 (favourable), Liver cancer:2.04e-4 (unfavourable), Colorectal cancer:6.81e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 13.8	Cell line enhanced		Daudi: 37.3;U-698: 41.3
ATG4B	APG4B, AUTL1, DKFZp586D1822, KIAA0943	ENSG00000168397	Autophagy related 4B cysteine peptidase	2	241637213-241673857	Enzymes, Predicted intracellular proteins	Evidence at protein level	CAB037195, HPA069803	Approved		Approved	Nucleoplasm<br>Cytosol	Renal cancer:2.79e-4 (unfavourable), Colorectal cancer:6.85e-4 (unfavourable), Urothelial cancer:9.64e-4 (favourable)	Expressed in all	Expressed in all			testis: 44.0	Expressed in all		
ZFYVE27	FLJ32919, SPG33	ENSG00000155256	Zinc finger FYVE-type containing 27	10	97737121-97760907	Disease related genes, Predicted membrane proteins	Evidence at protein level	HPA037523, HPA069876	Approved		Approved	Nucleoplasm<br>Cytosol	Colorectal cancer:6.91e-4 (unfavourable), Stomach cancer:7.54e-4 (favourable), Urothelial cancer:7.80e-4 (favourable)	Expressed in all	Expressed in all			cerebral cortex: 33.3	Expressed in all		
ENO2		ENSG00000111674	Enolase 2	12	6913745-6923698	Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB000063, HPA068284, HPA068721, CAB073539, CAB079023	Enhanced	Supported	Supported	Plasma membrane<br>Cytosol	Renal cancer:7.89e-11 (unfavourable), Liver cancer:5.15e-4 (unfavourable), Colorectal cancer:6.96e-4 (unfavourable)	Expressed in all	Tissue enriched	7	cerebral cortex: 431.0	parathyroid gland: 64.8	Cell line enhanced		U-87 MG: 368.8
NEK8	NPHP9	ENSG00000160602	NIMA related kinase 8	17	28725897-28743455	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Evidence at protein level	HPA040661, HPA040679	Approved				Lung cancer:4.52e-4 (favourable), Colorectal cancer:6.98e-4 (unfavourable)	Expressed in all	Mixed			thyroid gland: 9.7	Mixed		
STAC3	MGC2793	ENSG00000185482	SH3 and cysteine rich domain 3	12	57243453-57251193	Disease related genes, Predicted intracellular proteins	Evidence at protein level	HPA039285, HPA039527			Enhanced	Nucleoplasm<br>Cytosol	Renal cancer:7.11e-6 (unfavourable), Cervical cancer:2.01e-4 (favourable), Colorectal cancer:7.10e-4 (unfavourable)	Expressed in all	Tissue enriched	24	skeletal muscle: 802.4	prostate: 34.1	Cell line enriched	26	RH-30: 2201.5
ABCA7	ABCX	ENSG00000064687	ATP binding cassette subfamily A member 7	19	1040101-1065572	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Evidence at protein level	HPA041564	Enhanced		Supported	Golgi apparatus<br>Plasma membrane<br>Cell Junctions	Endometrial cancer:1.12e-4 (favourable), Colorectal cancer:7.26e-4 (unfavourable)	Expressed in all	Mixed			spleen: 25.3	Cell line enhanced		HMC-1: 52.2
TLX1	HOX11, TCL3	ENSG00000107807	T-cell leukemia homeobox 1	10	101130505-101137789	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Evidence at protein level						Colorectal cancer:7.32e-4 (unfavourable)	Mixed	Tissue enriched	5	spleen: 31.3	salivary gland: 6.0	Cell line enhanced		HAP1: 4.1;K-562: 10.7;SH-SY5Y: 2.9
ENO3		ENSG00000108515	Enolase 3	17	4948092-4957131	Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Evidence at protein level	HPA000793, HPA068284, HPA068721	Enhanced		Supported	Plasma membrane<br>Cytosol	Colorectal cancer:7.33e-4 (unfavourable)	Expressed in all	Tissue enriched	17	skeletal muscle: 5974.6	heart muscle: 350.1	Expressed in all		
FLNA	ABP-280, FLN, FLN1, OPD1, OPD2	ENSG00000196924	Filamin A	X	154348524-154374638	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters	Evidence at protein level	CAB000356, HPA000368, HPA001016, HPA001115, HPA002925	Enhanced	Approved	Enhanced	Plasma membrane<br>Actin filaments<br>Cytosol	Renal cancer:1.54e-6 (unfavourable), Urothelial cancer:3.88e-4 (unfavourable), Colorectal cancer:7.37e-4 (unfavourable)	Expressed in all	Expressed in all			smooth muscle: 1051.0	Expressed in all		
SHANK3	KIAA1650, prosap2, PSAP2, SPANK-2	ENSG00000251322	SH3 and multiple ankyrin repeat domains 3	22	50674415-50733298	Predicted intracellular proteins	Evidence at protein level	HPA003446, CAB079070	Enhanced	Approved			Colorectal cancer:7.40e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 2.7	Cell line enhanced		HEL: 3.8;TIME: 4.6
PKD1	PBP, Pc-1, TRPP1	ENSG00000008710	Polycystin 1, transient receptor potential channel interacting	16	2088710-2135898	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Evidence at protein level	CAB046448	Approved				Pancreatic cancer:3.38e-5 (favourable), Head and neck cancer:3.35e-4 (favourable), Colorectal cancer:7.43e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 21.6	Expressed in all		
ANGPTL4	ARP4, FIAF, HFARP, NL2, PGAR, pp1158	ENSG00000167772	Angiopoietin like 4	19	8363289-8374373	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA007879, CAB033770	Approved		Approved	Nucleoplasm<br>Vesicles	Renal cancer:1.34e-5 (unfavourable), Colorectal cancer:7.53e-4 (unfavourable), Lung cancer:9.50e-4 (unfavourable)	Expressed in all	Tissue enhanced		adipose tissue: 78.7	liver: 43.2	Cell line enhanced		HBEC3-KT: 161.5;TIME: 92.8;U-138 MG: 64.0
CD81	TAPA-1, TAPA1, TSPAN28	ENSG00000110651	CD81 molecule	11	2376177-2397419	CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Evidence at protein level	CAB002507, HPA007234	Supported		Supported	Plasma membrane	Glioma:5.12e-5 (unfavourable), Pancreatic cancer:3.86e-4 (favourable), Colorectal cancer:7.56e-4 (unfavourable)	Expressed in all	Expressed in all			seminal vesicle: 2273.0	Cell line enhanced		ASC diff: 2031.3
STAB1	CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1	ENSG00000010327	Stabilin 1	3	52495338-52524495	Predicted membrane proteins	Evidence at protein level	HPA005434	Approved		Approved	Nucleoplasm<br>Plasma membrane<br>Cytosol	Renal cancer:3.88e-7 (unfavourable), Colorectal cancer:7.59e-4 (unfavourable)	Expressed in all	Expressed in all			spleen: 123.3	Group enriched	38	HUVEC TERT2: 86.2;NB-4: 93.1;TIME: 104.8
RRAGB		ENSG00000083750	Ras related GTP binding B	X	55717739-55758774	Predicted intracellular proteins	Evidence at protein level	HPA003734	Approved		Approved	Golgi apparatus<br>Vesicles	Lung cancer:3.64e-6 (favourable), Glioma:5.36e-5 (favourable), Colorectal cancer:7.60e-4 (unfavourable)	Expressed in all	Expressed in all			epididymis: 42.3	Expressed in all		
GAA		ENSG00000171298	Glucosidase alpha, acid	17	80101556-80119879	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA026970, HPA029126	Enhanced				Colorectal cancer:7.66e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 69.7	Mixed		
C1orf35	MGC4174, MMTAG2	ENSG00000143793	Chromosome 1 open reading frame 35	1	228100726-228105411	Predicted intracellular proteins	Evidence at protein level	HPA046175	Approved		Approved	Nuclear speckles<br>Plasma membrane<br>Cytosol	Renal cancer:1.79e-6 (unfavourable), Ovarian cancer:7.38e-4 (favourable), Colorectal cancer:7.71e-4 (unfavourable)	Expressed in all	Expressed in all			skin: 14.3	Expressed in all		
G0S2		ENSG00000123689	G0/G1 switch 2	1	209675420-209676388	Predicted intracellular proteins	Evidence at protein level						Glioma:2.22e-4 (unfavourable), Renal cancer:3.14e-4 (unfavourable), Colorectal cancer:7.72e-4 (unfavourable)	Expressed in all	Group enriched	5	adipose tissue: 956.0;bone marrow: 937.9;skeletal muscle: 240.5	appendix: 138.1	Cell line enhanced		ASC diff: 321.2;HBEC3-KT: 528.5;PC-3: 170.1;RPMI-8226: 166.8
FAM134A	C2orf17, MAG-2, MGC3035	ENSG00000144567	Family with sequence similarity 134 member A	2	219176225-219185479	Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA011170, HPA011844	Approved		Approved	Cytosol	Liver cancer:1.49e-4 (unfavourable), Colorectal cancer:7.95e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 143.4	Expressed in all		
NRIP2	DKFZP761G1913	ENSG00000053702	Nuclear receptor interacting protein 2	12	2825348-2835544	Predicted intracellular proteins	Evidence at protein level	HPA039197, HPA039860	Enhanced		Approved	Nucleus<br>Nuclear bodies<br>Cytosol	Pancreatic cancer:8.69e-5 (favourable), Colorectal cancer:8.05e-4 (unfavourable)	Expressed in all	Mixed			endometrium: 12.4	Mixed		
KCTD7	CLN14, EPM3, FLJ32069	ENSG00000243335	Potassium channel tetramerization domain containing 7	7	66628767-66649067	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level						Pancreatic cancer:3.26e-4 (favourable), Colorectal cancer:8.07e-4 (unfavourable)	Expressed in all	Mixed			testis: 32.9	Expressed in all		
UCN	UI, UROC	ENSG00000163794	Urocortin	2	27307400-27308445	Predicted secreted proteins	Evidence at protein level	CAB010911	Approved		Approved	Endoplasmic reticulum	Renal cancer:1.84e-7 (unfavourable), Colorectal cancer:8.10e-4 (unfavourable)	Expressed in all	Mixed			cerebral cortex: 2.8	Cell line enhanced		U-266/70: 14.8
LZTS2	KIAA1813, LAPSER1	ENSG00000107816	Leucine zipper tumor suppressor 2	10	100996618-101007836	Predicted intracellular proteins	Evidence at protein level	HPA044956	Approved		Approved	Plasma membrane<br>Cytosol	Renal cancer:3.39e-4 (unfavourable), Colorectal cancer:8.23e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium,seminal vesicle: 57.9	Expressed in all		
HOXD9	HOX4, HOX4C	ENSG00000128709	Homeobox D9	2	176122720-176124937	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA068683			Supported	Nucleus<br>Nucleoli	Liver cancer:1.08e-5 (unfavourable), Colorectal cancer:8.25e-4 (unfavourable), Head and neck cancer:9.58e-4 (favourable)	Expressed in all	Tissue enhanced		endometrium: 45.4	smooth muscle: 23.7	Cell line enhanced		HEK 293: 14.8;RPTEC TERT1: 14.2;SH-SY5Y: 23.1;TIME: 13.8
BATF	B-ATF, BATF1, SFA-2	ENSG00000156127	Basic leucine zipper ATF-like transcription factor	14	75522425-75547015	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA059588, HPA064962	Approved		Enhanced	Nucleoplasm	Renal cancer:3.74e-9 (unfavourable), Endometrial cancer:5.35e-6 (favourable), Head and neck cancer:7.91e-5 (favourable), Urothelial cancer:4.30e-4 (favourable), Colorectal cancer:8.30e-4 (unfavourable)	Expressed in all	Tissue enhanced		lymph node: 31.4	appendix: 26.5	Cell line enhanced		HDLM-2: 321.9;MCF7: 99.6;RT4: 64.2;U-937: 74.7
PLIN4	KIAA1881, S3-12	ENSG00000167676	Perilipin 4	19	4502180-4518465	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA044682, HPA054657	Enhanced		Supported	Vesicles<br>Lipid droplets<br>Plasma membrane<br>Cytosol	Endometrial cancer:2.31e-4 (unfavourable), Colorectal cancer:8.31e-4 (unfavourable)	Mixed	Tissue enriched	14	adipose tissue: 812.2	skeletal muscle: 59.1	Cell line enriched	7	ASC diff: 171.0
ZNF653	Zip67	ENSG00000161914	Zinc finger protein 653	19	11483427-11505923	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA023631, HPA023635	Uncertain		Supported	Nucleus	Endometrial cancer:4.15e-4 (favourable), Colorectal cancer:8.37e-4 (unfavourable), Urothelial cancer:8.74e-4 (favourable)	Expressed in all	Mixed			testis: 19.0	Expressed in all		
FOLR2		ENSG00000165457	Folate receptor beta	11	72216601-72221950	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Evidence at protein level						Thyroid cancer:8.41e-4 (favourable), Colorectal cancer:8.42e-4 (unfavourable)	Expressed in all	Expressed in all			placenta: 235.4	Group enriched	6	Daudi: 2.6;U-698: 12.5
ITGA5	CD49e, FNRA	ENSG00000161638	Integrin subunit alpha 5	12	54395261-54419460	Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins	Evidence at protein level	HPA002642, CAB009008	Enhanced				Renal cancer:1.32e-8 (unfavourable), Cervical cancer:4.07e-6 (unfavourable), Liver cancer:2.23e-5 (unfavourable), Lung cancer:2.44e-4 (unfavourable), Head and neck cancer:2.91e-4 (unfavourable), Colorectal cancer:8.43e-4 (unfavourable), Thyroid cancer:8.89e-4 (unfavourable)	Expressed in all	Expressed in all			smooth muscle: 489.0	Cell line enhanced		HUVEC TERT2: 1106.4;TIME: 1039.6;U-87 MG: 602.5
LCAT		ENSG00000213398	Lecithin-cholesterol acyltransferase	16	67939750-67944131	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA044767			Approved	Nucleoplasm	Liver cancer:4.21e-8 (favourable), Renal cancer:1.71e-4 (unfavourable), Colorectal cancer:8.50e-4 (unfavourable)	Expressed in all	Expressed in all			liver: 105.7	Cell line enhanced		BEWO: 73.6
NR2C2AP	TRA16	ENSG00000184162	Nuclear receptor 2C2 associated protein	19	19201416-19203424	Predicted intracellular proteins	Evidence at protein level	HPA042054, HPA055653	Approved		Enhanced	Nucleoplasm	Liver cancer:5.63e-5 (unfavourable), Thyroid cancer:1.65e-4 (favourable), Colorectal cancer:8.53e-4 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 24.0	Expressed in all		
KCTD13	FKSG86, PDIP1, POLDIP1	ENSG00000174943	Potassium channel tetramerization domain containing 13	16	29905012-29927035	Predicted intracellular proteins	Evidence at protein level	HPA043524	Enhanced		Supported	Nucleus<br>Nuclear bodies	Renal cancer:8.17e-4 (unfavourable), Colorectal cancer:8.54e-4 (unfavourable), Pancreatic cancer:9.05e-4 (favourable)	Expressed in all	Mixed			testis: 12.5	Mixed		
SLC2A3	GLUT3	ENSG00000059804	Solute carrier family 2 member 3	12	7919230-7936275	Predicted membrane proteins, Transporters	Evidence at protein level	CAB002763, HPA006539	Approved		Approved	Plasma membrane	Renal cancer:6.36e-8 (unfavourable), Stomach cancer:2.89e-5 (unfavourable), Colorectal cancer:8.58e-4 (unfavourable)	Tissue enriched	Tissue enhanced		bone marrow: 271.2	placenta: 138.7	Group enriched	7	BEWO: 1387.7;CACO-2: 1315.8;NTERA-2: 293.2
SF3A2	Prp11, PRPF11, SAP62, SF3a66	ENSG00000104897	Splicing factor 3a subunit 2	19	2236504-2248679	Plasma proteins, Predicted intracellular proteins	Evidence at protein level	HPA042843, HPA049439	Enhanced		Approved	Nucleoplasm	Liver cancer:3.23e-5 (unfavourable), Renal cancer:2.07e-4 (unfavourable), Cervical cancer:7.16e-4 (favourable), Colorectal cancer:8.64e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 50.3	Expressed in all		
RUNX3	AML2, CBFA3, PEBP2A3	ENSG00000020633	Runt related transcription factor 3	1	24899511-24965121	Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA004195, CAB025416, HPA059006	Enhanced		Supported	Nucleus<br>Cytosol	Renal cancer:5.59e-5 (unfavourable), Colorectal cancer:8.71e-4 (unfavourable)	Expressed in all	Tissue enhanced		spleen: 50.5	bone marrow: 45.2	Cell line enhanced		HDLM-2: 125.1;Karpas-707: 125.3;SK-MEL-30: 77.0
OAZ2		ENSG00000180304	Ornithine decarboxylase antizyme 2	15	64687573-64703281	Predicted intracellular proteins	Evidence at protein level	HPA047694	Uncertain		Approved	Golgi apparatus	Colorectal cancer:9.05e-4 (unfavourable)	Expressed in all	Expressed in all			parathyroid gland: 118.1	Expressed in all		
KCNJ8	Kir6.1	ENSG00000121361	Potassium voltage-gated channel subfamily J member 8	12	21764955-21775581	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Evidence at protein level	HPA031066	Uncertain				Renal cancer:1.62e-6 (unfavourable), Colorectal cancer:9.29e-4 (unfavourable)	Expressed in all	Mixed			seminal vesicle: 32.0	Cell line enhanced		CACO-2: 71.9;SH-SY5Y: 31.1
TRAF2	TRAP3	ENSG00000127191	TNF receptor associated factor 2	9	136881912-136926607	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Evidence at protein level	CAB004603, HPA009972, HPA010634	Uncertain		Enhanced	Cytosol	Renal cancer:2.09e-4 (unfavourable), Liver cancer:3.06e-4 (unfavourable), Colorectal cancer:9.32e-4 (unfavourable)	Expressed in all	Expressed in all			lymph node: 22.5	Expressed in all		
PHF2	CENP-35, JHDM1E, KDM7C, KIAA0662	ENSG00000197724	PHD finger protein 2	9	93576407-93679587	Predicted intracellular proteins	Evidence at protein level	HPA010831	Approved				Renal cancer:1.12e-5 (favourable), Colorectal cancer:9.34e-4 (unfavourable)	Expressed in all	Expressed in all			endometrium: 30.7	Expressed in all		
KRI1	FLJ12949	ENSG00000129347	KRI1 homolog	19	10553078-10566037	Predicted intracellular proteins	Evidence at protein level	HPA043110, HPA043574	Approved		Enhanced	Nucleoli	Renal cancer:4.89e-10 (unfavourable), Liver cancer:1.21e-4 (unfavourable), Colorectal cancer:9.37e-4 (unfavourable)	Expressed in all	Expressed in all			appendix: 26.6	Expressed in all		
SIPA1	SPA1	ENSG00000213445	Signal-induced proliferation-associated 1	11	65638097-65650930	Predicted intracellular proteins	Evidence at protein level	CAB020833, HPA039867	Enhanced		Approved	Nucleus<br>Nucleoli<br>Golgi apparatus<br>Plasma membrane	Renal cancer:3.52e-6 (unfavourable), Colorectal cancer:9.42e-4 (unfavourable)	Expressed in all	Tissue enhanced		spleen: 99.7	lymph node: 71.0	Expressed in all		
CSAD	CSD, PCAP	ENSG00000139631	Cysteine sulfinic acid decarboxylase	12	53157663-53180909	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	HPA039487	Approved				Renal cancer:1.93e-6 (unfavourable), Urothelial cancer:6.81e-6 (favourable), Liver cancer:1.37e-4 (favourable), Pancreatic cancer:3.39e-4 (favourable), Head and neck cancer:6.33e-4 (favourable), Colorectal cancer:9.50e-4 (unfavourable)	Expressed in all	Expressed in all			skin: 70.7	Cell line enhanced		ASC diff: 57.9;T-47d: 49.5
TUT1	FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase	ENSG00000149016	Terminal uridylyl transferase 1, U6 snRNA-specific	11	62575045-62592177	Enzymes, Predicted intracellular proteins	Evidence at protein level	HPA069055, HPA071838			Supported	Nucleus<br>Cytosol	Colorectal cancer:9.51e-4 (unfavourable)	Expressed in all	Expressed in all			fallopian tube: 17.8	Expressed in all		
AGAP3	CENTG3	ENSG00000133612	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	7	151085831-151144436	Predicted intracellular proteins	Evidence at protein level	HPA012883	Approved				Renal cancer:8.58e-5 (unfavourable), Liver cancer:6.21e-4 (unfavourable), Colorectal cancer:9.52e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 92.5	Mixed		
SCAF1	FLJ00034, SR-A1	ENSG00000126461	SR-related CTD associated factor 1	19	49642125-49658642	Predicted intracellular proteins	Evidence at protein level	HPA046828, HPA054593	Approved		Approved	Nucleoplasm<br>Cytosol	Colorectal cancer:9.59e-4 (unfavourable)	Expressed in all	Expressed in all			cerebral cortex: 51.6	Expressed in all		
CLASRP	CLASP, SFRS16, SWAP2	ENSG00000104859	CLK4 associating serine/arginine rich protein	19	45039040-45070956	Predicted intracellular proteins	Evidence at protein level	HPA060469, HPA062455	Approved		Enhanced	Nucleus	Renal cancer:1.69e-8 (unfavourable), Urothelial cancer:1.02e-5 (favourable), Colorectal cancer:9.77e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 11.9	Expressed in all		
NR1H2	LXR-b, NER, NER-I, RIP15, UNR	ENSG00000131408	Nuclear receptor subfamily 1 group H member 2	19	50329653-50382982	Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Evidence at protein level	HPA056838, HPA070212	Uncertain		Approved	Nucleoplasm	Colorectal cancer:9.86e-4 (unfavourable)	Expressed in all	Expressed in all			bone marrow: 87.6	Expressed in all		
C9orf16	EST00098, FLJ12823, MGC4639	ENSG00000171159	Chromosome 9 open reading frame 16	9	128160260-128163928	Predicted intracellular proteins	Evidence at protein level	HPA020725	Uncertain		Approved	Microtubules	Liver cancer:3.13e-5 (unfavourable), Cervical cancer:7.60e-4 (favourable), Colorectal cancer:9.91e-4 (unfavourable)	Expressed in all	Expressed in all			adrenal gland: 151.4	Expressed in all		
PHKG2		ENSG00000156873	Phosphorylase kinase catalytic subunit gamma 2	16	30748270-30761176	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Evidence at protein level	HPA065618, HPA068751			Supported	Cytosol	Lung cancer:1.90e-4 (favourable), Cervical cancer:7.90e-4 (favourable), Pancreatic cancer:8.02e-4 (favourable), Colorectal cancer:9.92e-4 (unfavourable)	Expressed in all	Expressed in all			testis: 149.4	Expressed in all		
SERPING1	C1-INH, C1IN, C1NH, HAE1, HAE2	ENSG00000149131	Serpin family G member 1	11	57597387-57614853	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Evidence at protein level	CAB026161, HPA048738	Supported				Renal cancer:1.55e-4 (unfavourable), Ovarian cancer:8.03e-4 (favourable), Colorectal cancer:9.96e-4 (unfavourable)	Expressed in all	Expressed in all			liver: 1365.0	Group enriched	5	ASC diff: 881.8;ASC TERT1: 462.5;HSkMC: 802.1
